{"gene":"RAI1","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":2000,"finding":"S. cerevisiae Rai1p (YGL246c) physically binds the nuclear 5'→3' exoribonuclease Rat1p and stabilizes its in vitro exoribonuclease activity. Deletion of RAI1 is synthetically lethal with the rat1-1(ts) mutation, placing Rai1p as a functional partner of Rat1p in nuclear RNA processing and 5.8S rRNA maturation.","method":"Yeast two-hybrid, co-purification, in vitro exoribonuclease assay, genetic epistasis (synthetic lethality), Northern blot rRNA analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal genetic and biochemical evidence (purified protein stimulation assay + synthetic lethality + rRNA processing phenotype) in a single rigorous study","pmids":["10805743"],"is_preprint":false},{"year":2003,"finding":"RAI1 encodes a nuclear protein highly expressed in neuronal tissues; the human gene comprises six exons producing a 7.6-kb mRNA and contains a polymorphic CAG repeat coding for a polyglutamine stretch in the N-terminal domain.","method":"cDNA cloning, RT-PCR expression profiling, genomic sequencing","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — direct molecular characterization but no functional assay beyond expression; single study","pmids":["12837267"],"is_preprint":false},{"year":2003,"finding":"Dominant frameshift mutations causing protein truncation in RAI1 are sufficient to produce Smith-Magenis syndrome features in the absence of 17p11.2 deletions, establishing RAI1 haploinsufficiency as the molecular basis for SMS.","method":"Sequencing of RAI1 in non-deletion SMS patients; frameshift mutation identification","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple independent patients with truncating mutations, replicated by subsequent studies; foundational genetic finding","pmids":["12652298"],"is_preprint":false},{"year":2004,"finding":"Bioinformatics analysis of RAI1 protein sequence identified a conserved zinc finger-like plant homeodomain (PHD) at the C-terminus, homologous to trithorax-group chromatin-based transcription regulators, suggesting RAI1 functions in transcriptional control through a multi-protein chromatin-regulatory complex.","method":"Bioinformatics/comparative genomics (human–mouse ortholog alignment); PHD domain identification","journal":"Human genetics","confidence":"Low","confidence_rationale":"Tier 4 — computational prediction; no direct functional assay of PHD domain in this study","pmids":["15565467"],"is_preprint":false},{"year":2005,"finding":"Heterozygous Rai1 null mice (generated by gene targeting with lacZ insertion) recapitulate SMS features including obesity and craniofacial abnormalities. GFP-Rai1 fusion protein localizes to the nucleus and the GAL4-Rai1 fusion has transactivation activity, demonstrating that Rai1 is a nuclear transcriptional activator.","method":"Gene targeting/knockout mice, X-gal staining, GFP subcellular localization, GAL4 transactivation reporter assay","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 — direct transactivation assay + nuclear localization experiment + in vivo knockout phenotype; multiple orthogonal methods","pmids":["15746153"],"is_preprint":false},{"year":2006,"finding":"Restoring normal disomic Rai1 dosage in Dp(11)17/+ mice by combining the duplication with a Rai1 null allele rescues the complex physical and behavioral phenotypes, demonstrating that RAI1 copy number is the primary dosage-sensitive determinant of both SMS and dup(17)(p11.2) phenotypes.","method":"Compound heterozygous mouse genetics; behavioral and physical phenotyping of Dp(11)17/Rai1(-) mice","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — genetic rescue experiment with defined single-gene dosage manipulation; strong phenotypic rescue","pmids":["17024248"],"is_preprint":false},{"year":2007,"finding":"Rai1 homozygous null mice display severe learning and motor deficits, hind limb clasping, overt seizures, and context/tone-dependent learning deficits. X-gal staining reveals Rai1 is predominantly expressed in hippocampal and cerebellar neurons, and Rai1 functions in a dosage-sensitive manner in the CNS.","method":"Behavioral testing battery (locomotion, EEG, context/tone fear conditioning), X-gal staining of Rai1+/- brain sections","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with specific neurological phenotypic readouts + direct localization by reporter staining","pmids":["17517686"],"is_preprint":false},{"year":2008,"finding":"Rai1-transgenic mice overexpressing Rai1 >1.5-fold show growth retardation, increased locomotor activity, abnormal anxiety behavior, altered gait, decreased grip strength, and dominant social behavior; homozygous transgenic mice show dosage-dependent exacerbation including severe neurological deficits, confirming that RAI1 operates with strict dosage thresholds for normal development.","method":"Transgenic mouse overexpression (hemizygous and homozygous), behavioral phenotyping, grip strength, gait analysis","journal":"European journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — dose-response genetic experiment with multiple phenotypic readouts; replicates dosage sensitivity concept","pmids":["18285828"],"is_preprint":false},{"year":2009,"finding":"Crystal structures of S. pombe Rat1 in complex with Rai1 (2.2 Å), and of Rai1 and murine Dom3Z alone (2.0 Å) reveal the molecular mechanism by which Rai1 activates Rat1 exoribonuclease activity and enables Rat1 to degrade RNAs with stable secondary structures. A conserved active-site pocket in Rai1/Dom3Z with three acidic residues coordinates a divalent cation; mutagenesis and biochemical assays demonstrate that Rai1 possesses pyrophosphohydrolase activity toward 5′-triphosphorylated RNA — the first demonstration of this activity in eukaryotes.","method":"X-ray crystallography, in vitro exoribonuclease assay, pyrophosphohydrolase activity assay, active-site mutagenesis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — crystal structure at 2.0–2.2 Å + mutagenesis + multiple biochemical assays; single rigorous paper with orthogonal methods","pmids":["19194460"],"is_preprint":false},{"year":2010,"finding":"Full-length human RAI1 protein localizes to the nucleus and activates transcription of a reporter gene. Frameshift truncation mutations (N-terminal half) cause cytoplasmic mislocalization and loss of transactivation of BDNF enhancer; missense mutations in the C-terminal half retain nuclear localization but abolish transactivation. Transcription factor activity and nuclear localization signals reside in distinct protein domains.","method":"Western blot, immunofluorescence localization, luciferase reporter transactivation assay with wild-type and mutant RAI1 constructs","journal":"BMC molecular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple domain-deletion/mutation constructs with orthogonal localization and transactivation readouts; replicated in patient lymphoblastoid cells","pmids":["20738874"],"is_preprint":false},{"year":2012,"finding":"RAI1 directly regulates transcription of CLOCK, a master circadian oscillator gene. Haploinsufficiency of RAI1 in SMS patient fibroblasts and Rai1+/- mouse hypothalamus disrupts circadian clock gene expression including PER2, PER3, CRY1, and BMAL1, demonstrating RAI1 as a positive transcriptional regulator of CLOCK and a critical component of the mammalian circadian oscillator.","method":"Luciferase promoter reporter assay (CLOCK promoter), RT-qPCR of circadian genes in patient fibroblasts and mouse hypothalamus, circadian gene expression profiling","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — direct promoter assay combined with patient cell and mouse tissue validation; multiple circadian gene targets measured; replicated across cell and animal models","pmids":["22578325"],"is_preprint":false},{"year":2012,"finding":"SMS patient-derived lymphoblastoid cells carrying RAI1 c.3103insC mutation show the mutant truncated protein in cytoplasmic fractions while wild-type RAI1 localizes to chromatin-bound and nuclear matrix fractions, confirming that N-terminal truncations of RAI1 displace the protein from chromatin and abolish BDNF enhancer-directed transactivation.","method":"Subcellular fractionation (chromatin-bound, nuclear matrix, cytoplasmic), immunoblot, BDNF-luciferase reporter in patient lymphoblastoid cells","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — subcellular fractionation with functional consequence (transactivation loss) validated in patient-derived cells","pmids":["23028815"],"is_preprint":false},{"year":2013,"finding":"RAI1 protein contains a C-terminal ePHD/ADD-like chromatin-binding domain and a novel nucleosome-binding region (NBR) that is highly conserved in vertebrates. In vitro and yeast experiments show the ePHD/ADD-like domain adopts a cross-braced zinc finger topology. The conserved NBR of RAI1 directly binds the nucleosome core and histones.","method":"In vitro pull-down (nucleosome core binding), yeast two-hybrid, phylogenetic/domain analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 — single pull-down for nucleosome binding + yeast interaction + computational topology; moderate evidence","pmids":["24205348"],"is_preprint":false},{"year":2013,"finding":"Free-running circadian period lengths are shortened in Rai1+/- mice (gene knock-out) and Df(11)17-2/+ deletion mice but not in Dexras1+/- mice, indicating that Rai1 is the primary gene underlying circadian period defects in Smith-Magenis syndrome models.","method":"Free-running period length measurement (locomotor activity in constant dark) in multiple mouse models","journal":"American journal of medical genetics. Part A","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis/comparison across multiple mouse models with quantitative circadian phenotype readout","pmids":["23703963"],"is_preprint":false},{"year":2014,"finding":"Knockdown of Rai1 in Xenopus laevis/tropicalis using antisense morpholinos causes midface hypoplasia, malformed mouth, aberrant neural crest cell migration, reduced facial cartilage, abnormal axon patterns, decreased forebrain ventricle size, decreased bdnf expression, and increased forebrain apoptosis, revealing a conserved developmental role for Rai1 in neural crest-dependent craniofacial development and neuronal survival.","method":"Antisense morpholino knockdown, in situ hybridization, immunostaining, TUNEL apoptosis assay in Xenopus embryos","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function in vertebrate model with multiple cellular/molecular phenotypic readouts","pmids":["24878353"],"is_preprint":false},{"year":2015,"finding":"Crystal structures of fungal Rai1 homologs bound to RNA oligonucleotides reveal differences in RNA-binding modes that underlie distinct activity profiles (pyrophosphohydrolase vs. triphosphonucleotide hydrolase). Structure-based mutations of poorly conserved residues contacting RNA substantially alter enzymatic activities, establishing the active-site tunnel as the single locus for PPH, decapping, and exonuclease activities.","method":"X-ray crystallography, structure-based mutagenesis, RNA enzyme activity assays (PPH, decapping, 5'→3' exonuclease, TPH)","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — crystal structures with RNA bound + mutagenesis + multiple activity assays; rigorous mechanistic study","pmids":["26101253"],"is_preprint":false},{"year":2016,"finding":"Rai1 preferentially occupies DNA regions near active promoters (ChIP-seq in mouse brain) and promotes expression of genes involved in circuit assembly and neuronal communication. Pan-neural Rai1 loss causes deficits in motor function, learning, and food intake; Rai1 loss in inhibitory neurons or subcortical glutamatergic neurons causes learning deficits, while Rai1 loss in Sim1+ or SF1+ hypothalamic cells causes obesity.","method":"ChIP-seq (Rai1 chromatin occupancy), conditional Cre/loxP neuron-type-specific knockouts, behavioral testing (motor, learning, feeding)","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1–2 — genome-wide chromatin binding map + multiple cell-type-specific conditional knockouts with defined phenotypic readouts; strong mechanistic resolution","pmids":["27693255"],"is_preprint":false},{"year":2018,"finding":"Normalizing Rai1 levels in Rai1 heterozygous mice at 3–4 weeks postnatal (early adolescence) corrects expression of neural developmental pathway genes and fully reverses a social interaction deficit; Rai1 reactivation at 7–8 weeks is not beneficial, defining a postnatal critical window. Correct Rai1 dosage is required in both excitatory and inhibitory neurons for proper social interaction.","method":"Conditional Rai1 reactivation (tet-inducible allele) at defined postnatal timepoints, RNA-seq, social interaction behavioral testing, dendritic spine quantification, optogenetics","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — inducible genetic rescue with temporal precision + transcriptomics + behavioral endpoints; multiple orthogonal methods","pmids":["30275311"],"is_preprint":false},{"year":2020,"finding":"DXO/Rai1 enzymes remove FAD and dephospho-CoA (dpCoA) non-canonical caps from RNA (deFADding and deCoAping activities). Crystal structures of mammalian DXO with 3′-FADP or CoA, and fission yeast Rai1 with 3′-FADP, show FAD and CoA adopt folded conformations in the active-site tunnel; the flavin of FAD and pantetheine of CoA contact the same region, with conformational changes accommodating different caps. FAD-capped RNAs (<200 nt) are detected in human cells and stabilized in DXO-null cells.","method":"X-ray crystallography (DXO–FADP, DXO–CoA, Rai1–FADP complexes), in vitro deFADding/deCoAping enzyme assays, FAD-capQ detection in human cells, DXO knockout cells","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — crystal structures with substrates + in vitro enzymatic assays + cellular validation with KO cells","pmids":["32374864"],"is_preprint":false},{"year":2020,"finding":"RAI1 binds dynamically to chromatin near active promoters in response to changes in neuronal network activity and is required for activity-dependent nascent transcription. RAI1 suppresses synaptic upscaling in naive networks while promoting upscaling triggered by activity silencing; Rai1-deficient neurons show altered electrophysiological properties consistent with defective homeostatic synaptic plasticity.","method":"Nascent RNA sequencing (EU-seq), ChIP-seq (dynamic chromatin occupancy), whole-cell patch clamp electrophysiology in Rai1-deficient neurons","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — nascent transcriptomics + dynamic ChIP-seq + electrophysiology in KO neurons; multiple orthogonal methods","pmids":["32783930"],"is_preprint":false},{"year":2021,"finding":"ALKBH5-mediated m6A demethylation of pri-miR-194-2 inhibits miR-194-2 biogenesis in an m6A/DGCR8-dependent manner; RAI1 is the primary target of miR-194-2. RAI1 enhances transcription of Hippo pathway upstream genes by binding to their 3′UTR and suppresses YAP/TAZ nuclear translocation, functioning as a transcriptional enhancer in the Hippo pathway.","method":"m6A-seq, DGCR8 RIP, miRNA target validation (luciferase 3′UTR reporter), ChIP/RNA pull-down (RAI1 binding to 3′UTR), YAP/TAZ nuclear translocation assay, in vitro and xenograft models","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple functional assays but mechanistic link (RAI1 binding 3′UTR to enhance Hippo transcription) is somewhat unusual and from a single lab","pmids":["34312488"],"is_preprint":false}],"current_model":"RAI1 is a dosage-sensitive nuclear transcriptional activator that occupies active promoters via conserved PHD/ePHD chromatin-reader and nucleosome-binding domains, directly regulates transcription of CLOCK and activity-dependent neuronal genes (including BDNF enhancer targets), controls homeostatic synaptic scaling, and governs circadian rhythmicity and hypothalamic energy balance in a cell-type-specific manner; its yeast/fungal orthologs additionally possess enzymatic activities (pyrophosphohydrolase, decapping, deFADding, deCoAping) directed at non-canonical RNA 5′-end caps, and physically activate the Rat1/XRN2 5′→3′ exoribonuclease through direct complex formation."},"narrative":{"teleology":[{"year":2000,"claim":"Identification of a physical and functional partnership between yeast Rai1p and the nuclear exoribonuclease Rat1p established the founding biochemical activity of the Rai1 family — stabilizing and stimulating 5′→3′ exoribonuclease activity and participating in rRNA processing.","evidence":"Yeast two-hybrid, co-purification, in vitro exoribonuclease stimulation assay, synthetic lethality with rat1-1(ts), Northern blot rRNA analysis in S. cerevisiae","pmids":["10805743"],"confidence":"High","gaps":["Whether mammalian RAI1 retains exoribonuclease-stimulating or pyrophosphohydrolase activity was unknown","Relevance of the Rat1 partnership to metazoan RAI1 function not tested"]},{"year":2003,"claim":"Cloning of human RAI1 and discovery that truncating mutations in RAI1 alone are sufficient to produce Smith–Magenis syndrome established RAI1 haploinsufficiency as the molecular basis for SMS, separating it from the broader 17p11.2 contiguous gene deletion.","evidence":"cDNA cloning, mutation screening of non-deletion SMS patients identifying frameshift mutations, RT-PCR expression profiling","pmids":["12652298","12837267"],"confidence":"High","gaps":["Molecular function of RAI1 protein in mammalian cells was entirely uncharacterized","No structural or biochemical data for mammalian RAI1"]},{"year":2005,"claim":"Demonstration that RAI1 is a nuclear protein with intrinsic transcriptional activation activity, and that heterozygous Rai1-null mice recapitulate SMS phenotypes, provided the first functional classification of RAI1 as a dosage-sensitive transcriptional activator.","evidence":"Gene-targeted Rai1-null mice, GFP-Rai1 nuclear localization, GAL4-Rai1 transactivation reporter assay","pmids":["15746153"],"confidence":"High","gaps":["Target genes of RAI1 transactivation unknown","Chromatin-binding mechanism unresolved","Pathway specificity of dosage sensitivity not addressed"]},{"year":2006,"claim":"Genetic rescue of the dup(17)(p11.2) mouse phenotype by normalizing Rai1 copy number proved that RAI1 is the critical dosage-sensitive gene underlying both deletion (SMS) and duplication (Potocki–Lupski) syndromes.","evidence":"Compound heterozygous Dp(11)17/Rai1-null mouse genetics with behavioral and physical phenotyping","pmids":["17024248"],"confidence":"High","gaps":["Cellular and circuit-level mechanisms of dosage sensitivity not identified","Whether dosage effects are transcriptional or post-transcriptional unknown"]},{"year":2009,"claim":"Crystal structures of the S. pombe Rat1–Rai1 complex and free Rai1/Dom3Z revealed the structural basis by which Rai1 activates Rat1 exoribonuclease activity, and uncovered an intrinsic pyrophosphohydrolase activity in the Rai1 active-site pocket — the first such eukaryotic activity — broadening the enzymatic repertoire of the family.","evidence":"X-ray crystallography (2.0–2.2 Å), in vitro exoribonuclease and pyrophosphohydrolase assays, active-site mutagenesis","pmids":["19194460"],"confidence":"High","gaps":["Whether mammalian RAI1 retains enzymatic activity or only transcriptional function was unclear","Structural basis for mammalian RAI1 chromatin interaction not addressed"]},{"year":2010,"claim":"Domain-dissection of human RAI1 established that N-terminal truncation mutations displace the protein from the nucleus and abolish BDNF enhancer transactivation, while C-terminal missense mutations retain nuclear localization but still lose transactivation, defining separable localization and activation domains.","evidence":"Immunofluorescence, luciferase reporter assays with wild-type and mutant RAI1 constructs, patient lymphoblastoid cell fractionation","pmids":["20738874","23028815"],"confidence":"High","gaps":["Identity of direct chromatin-binding domain not resolved","Genome-wide target repertoire unknown"]},{"year":2012,"claim":"Discovery that RAI1 directly activates the CLOCK promoter and that RAI1 haploinsufficiency disrupts downstream circadian gene oscillation established RAI1 as a transcriptional regulator of the mammalian circadian clock.","evidence":"CLOCK promoter-luciferase reporter, RT-qPCR of circadian genes in SMS patient fibroblasts and Rai1+/− mouse hypothalamus","pmids":["22578325"],"confidence":"High","gaps":["Whether RAI1 binds CLOCK promoter chromatin directly (ChIP) not shown","Mechanism linking RAI1 to circadian period length not fully resolved"]},{"year":2013,"claim":"Identification of a conserved ePHD/ADD-like domain and a nucleosome-binding region in RAI1, combined with demonstration of direct nucleosome core binding, provided the first chromatin-reader mechanism for how RAI1 engages its genomic targets; concurrently, free-running circadian period shortening in Rai1+/− mice confirmed RAI1 as the gene responsible for SMS-associated circadian defects.","evidence":"In vitro nucleosome pull-down, yeast two-hybrid for ePHD topology, free-running locomotor activity in constant darkness across multiple mouse models","pmids":["24205348","23703963"],"confidence":"Medium","gaps":["ePHD/nucleosome-binding interaction lacks structural resolution at atomic level","Histone mark specificity of ePHD reader not determined","In vivo ChIP validation of nucleosome-binding region absent"]},{"year":2015,"claim":"Crystal structures of fungal Rai1 homologs bound to RNA substrates revealed how active-site tunnel geometry dictates substrate specificity among pyrophosphohydrolase, decapping, and triphosphonucleotide hydrolase activities, unifying diverse cap-removal functions in a single catalytic locus.","evidence":"X-ray crystallography with RNA oligonucleotides, structure-based mutagenesis, PPH/decapping/exonuclease activity assays","pmids":["26101253"],"confidence":"High","gaps":["Catalytic activities demonstrated for fungal orthologs; metazoan RAI1 enzymatic activity not confirmed","In vivo RNA substrates of Rai1 cap-removal not identified"]},{"year":2016,"claim":"Genome-wide ChIP-seq demonstrated that Rai1 preferentially occupies active promoters in mouse brain, and cell-type-specific conditional knockouts revealed circuit-level division of labor: hypothalamic Rai1 controls energy balance while cortical/subcortical Rai1 governs learning and motor function.","evidence":"ChIP-seq in mouse brain, Cre/loxP conditional knockouts in inhibitory, excitatory, Sim1+, and SF1+ neurons with behavioral phenotyping","pmids":["27693255"],"confidence":"High","gaps":["Cofactors mediating RAI1 recruitment to active promoters unidentified","Mechanism by which RAI1 activates transcription at bound promoters unknown"]},{"year":2018,"claim":"Temporal genetic rescue experiments defined a postnatal critical window (~3–4 weeks) during which restoring Rai1 dosage normalizes neural gene expression and social behavior, demonstrating that RAI1 function is required during a developmental period and not merely for ongoing maintenance.","evidence":"Tet-inducible Rai1 reactivation at defined postnatal ages, RNA-seq, social interaction testing, dendritic spine analysis","pmids":["30275311"],"confidence":"High","gaps":["Molecular basis of the critical window closure unknown","Whether the window applies to all SMS phenotypes or only social behavior untested"]},{"year":2020,"claim":"Two advances converged: (1) structural and biochemical demonstration that DXO/Rai1 enzymes remove non-canonical FAD and CoA caps from RNA, expanding the cap-removal repertoire; and (2) dynamic ChIP-seq and nascent transcriptomics showing RAI1 chromatin occupancy responds to neuronal activity changes and is required for homeostatic synaptic scaling, connecting RAI1 to activity-dependent gene regulation and synaptic plasticity.","evidence":"X-ray crystallography (DXO–FADP, Rai1–FADP), in vitro deFADding/deCoAping assays, DXO-KO cells; EU-seq, dynamic ChIP-seq, whole-cell patch clamp in Rai1-deficient neurons","pmids":["32374864","32783930"],"confidence":"High","gaps":["Whether mammalian RAI1 (as opposed to DXO) retains deFADding/deCoAping activity in neurons is untested","Specific activity-dependent target genes directly controlled by RAI1 chromatin binding not fully catalogued","Structural basis for mammalian RAI1 chromatin engagement still lacking"]},{"year":null,"claim":"Key unresolved questions include: whether mammalian RAI1 retains any enzymatic (cap-removal) activity or functions exclusively as a transcription factor; the structural basis of RAI1's ePHD-mediated chromatin reading and histone-mark specificity; the identity of RAI1's cofactors and the transcriptional complex it operates within; and the molecular mechanism defining the postnatal critical window for RAI1-dependent circuit maturation.","evidence":"Open questions arising from the literature","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of mammalian RAI1 available","No identified cofactors or chromatin-remodeling complex partners","Enzymatic versus transcriptional roles in mammalian neurons not delineated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[4,9,10,11,16,19]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[16,19]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[12]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[8,15,18]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,4,9,11]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[11,12,16,19]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,9,10,16,19]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[12,16,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[14,17]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[6,16,17,19]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,8,15,18]}],"complexes":[],"partners":["CLOCK","BDNF","RAT1","XRN2"],"other_free_text":[]},"mechanistic_narrative":"RAI1 is a dosage-sensitive nuclear transcriptional activator essential for neurodevelopment, circadian rhythmicity, and energy homeostasis. It localizes to chromatin via a C-terminal ePHD/ADD-like domain and a conserved nucleosome-binding region, occupies active promoters in a neuronal activity-dependent manner, and directly transactivates targets including CLOCK and BDNF enhancer elements [PMID:22578325, PMID:32783930, PMID:24205348]. Haploinsufficiency of RAI1 causes Smith–Magenis syndrome, while its overexpression produces Potocki–Lupski syndrome features, reflecting strict copy-number thresholds for normal CNS function [PMID:12652298, PMID:17024248]. Cell-type-specific conditional knockouts demonstrate that RAI1 in hypothalamic neurons governs body weight, while its activity in cortical excitatory and inhibitory neurons controls homeostatic synaptic scaling, social behavior, and learning within a postnatal critical window [PMID:27693255, PMID:30275311, PMID:32783930]."},"prefetch_data":{"uniprot":{"accession":"Q7Z5J4","full_name":"Retinoic acid-induced protein 1","aliases":[],"length_aa":1906,"mass_kda":203.4,"function":"Transcriptional regulator of the circadian clock components: CLOCK, BMAL1, BMAL2, PER1/3, CRY1/2, NR1D1/2 and RORA/C. Positively regulates the transcriptional activity of CLOCK a core component of the circadian clock. Regulates transcription through chromatin remodeling by interacting with other proteins in chromatin as well as proteins in the basic transcriptional machinery. May be important for embryonic and postnatal development. May be involved in neuronal differentiation","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q7Z5J4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RAI1","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CAPZB","stoichiometry":0.2},{"gene":"CSNK1A1","stoichiometry":0.2},{"gene":"H1F0","stoichiometry":0.2},{"gene":"H2AFZ","stoichiometry":0.2},{"gene":"HDAC1","stoichiometry":0.2},{"gene":"HDAC2","stoichiometry":0.2},{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"HMGA1","stoichiometry":0.2},{"gene":"HMGN5","stoichiometry":0.2},{"gene":"KPNA4","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/RAI1","total_profiled":1310},"omim":[{"mim_id":"616652","title":"YUAN-HAREL-LUPSKI SYNDROME; YUHAL","url":"https://www.omim.org/entry/616652"},{"mim_id":"616364","title":"WHITE-SUTTON SYNDROME; WHSUS","url":"https://www.omim.org/entry/616364"},{"mim_id":"614787","title":"POGO TRANSPOSABLE ELEMENT-DERIVED PROTEIN WITH ZNF DOMAIN; POGZ","url":"https://www.omim.org/entry/614787"},{"mim_id":"614168","title":"PHOSPHOENOLPYRUVATE CARBOXYKINASE 1, SOLUBLE; PCK1","url":"https://www.omim.org/entry/614168"},{"mim_id":"613970","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6","url":"https://www.omim.org/entry/613970"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RAI1"},"hgnc":{"alias_symbol":["DKFZP434A139","SMS","KIAA1820","MGC12824"],"prev_symbol":["SMCR"]},"alphafold":{"accession":"Q7Z5J4","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z5J4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z5J4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z5J4-F1-predicted_aligned_error_v6.png","plddt_mean":39.53},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RAI1","jax_strain_url":"https://www.jax.org/strain/search?query=RAI1"},"sequence":{"accession":"Q7Z5J4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q7Z5J4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q7Z5J4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z5J4"}},"corpus_meta":[{"pmid":"8132773","id":"PMC_8132773","title":"Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.","date":"1994","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8132773","citation_count":264,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12652298","id":"PMC_12652298","title":"Mutations in RAI1 associated with Smith-Magenis syndrome.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12652298","citation_count":244,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19854632","id":"PMC_19854632","title":"A daily SMS reminder increases adherence to asthma treatment: a three-month follow-up study.","date":"2009","source":"Respiratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19854632","citation_count":218,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2883060","id":"PMC_2883060","title":"Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.","date":"1987","source":"Digestion","url":"https://pubmed.ncbi.nlm.nih.gov/2883060","citation_count":217,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19848576","id":"PMC_19848576","title":"Computerized Automated Reminder Diabetes System (CARDS): e-mail and SMS cell phone text messaging reminders to support diabetes management.","date":"2009","source":"Diabetes technology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/19848576","citation_count":188,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19194460","id":"PMC_19194460","title":"Structure and function of the 5'-->3' exoribonuclease Rat1 and its activating partner Rai1.","date":"2009","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/19194460","citation_count":171,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2903168","id":"PMC_2903168","title":"Preoperative treatment of acromegaly with long-acting somatostatin analog SMS 201-995: shrinkage of invasive pituitary macroadenomas and improved surgical remission rate.","date":"1988","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/2903168","citation_count":165,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14508504","id":"PMC_14508504","title":"X-linked spermine synthase gene (SMS) defect: the first polyamine deficiency syndrome.","date":"2003","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/14508504","citation_count":146,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22106271","id":"PMC_22106271","title":"Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22106271","citation_count":133,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2563240","id":"PMC_2563240","title":"Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism.","date":"1989","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/2563240","citation_count":129,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26760452","id":"PMC_26760452","title":"Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda.","date":"2016","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26760452","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17616479","id":"PMC_17616479","title":"Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17616479","citation_count":106,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7882976","id":"PMC_7882976","title":"Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SSTR2 somatostatin receptor.","date":"1995","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7882976","citation_count":105,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10805743","id":"PMC_10805743","title":"Saccharomyces cerevisiae RAI1 (YGL246c) is homologous to human DOM3Z and encodes a protein that binds the nuclear exoribonuclease Rat1p.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10805743","citation_count":103,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2893555","id":"PMC_2893555","title":"Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.","date":"1988","source":"American journal of surgery","url":"https://pubmed.ncbi.nlm.nih.gov/2893555","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12446634","id":"PMC_12446634","title":"Role for radA/sms in recombination intermediate processing in Escherichia coli.","date":"2002","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/12446634","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2537716","id":"PMC_2537716","title":"Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.","date":"1989","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/2537716","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15565467","id":"PMC_15565467","title":"Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome.","date":"2004","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15565467","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12947096","id":"PMC_12947096","title":"SmcR and cyclic AMP receptor protein coactivate Vibrio vulnificus vvpE encoding elastase through the RpoS-dependent promoter in a synergistic manner.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12947096","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22578325","id":"PMC_22578325","title":"Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity.","date":"2012","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22578325","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9681834","id":"PMC_9681834","title":"p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9681834","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11997339","id":"PMC_11997339","title":"Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs.","date":"2002","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11997339","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10915763","id":"PMC_10915763","title":"CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2).","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10915763","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15746153","id":"PMC_15746153","title":"Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome.","date":"2005","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15746153","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20841743","id":"PMC_20841743","title":"Cell phone short messaging service (SMS) for HIV/AIDS in South Africa: a literature review.","date":"2010","source":"Studies in health technology and informatics","url":"https://pubmed.ncbi.nlm.nih.gov/20841743","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16834364","id":"PMC_16834364","title":"Single-molecule spectroelectrochemistry (SMS-EC).","date":"2006","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/16834364","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17517686","id":"PMC_17517686","title":"Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17517686","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29077507","id":"PMC_29077507","title":"Multiethnic Meta-Analysis Identifies RAI1 as a Possible Obstructive Sleep Apnea-related Quantitative Trait Locus in Men.","date":"2018","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29077507","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22437844","id":"PMC_22437844","title":"The bHLH Rac Immunity1 (RAI1) Is Activated by OsRac1 via OsMAPK3 and OsMAPK6 in Rice Immunity.","date":"2012","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22437844","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8754775","id":"PMC_8754775","title":"Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells.","date":"1996","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8754775","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1281776","id":"PMC_1281776","title":"UK-14,304, R(-)-alpha-methyl-histamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms.","date":"1992","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/1281776","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17024248","id":"PMC_17024248","title":"Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2).","date":"2006","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17024248","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18694848","id":"PMC_18694848","title":"The domain responsible for sphingomyelin synthase (SMS) activity.","date":"2008","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/18694848","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27693255","id":"PMC_27693255","title":"Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome.","date":"2016","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/27693255","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24863970","id":"PMC_24863970","title":"Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity.","date":"2014","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24863970","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23897607","id":"PMC_23897607","title":"LuxR homologue SmcR is essential for Vibrio vulnificus pathogenesis and biofilm detachment, and its expression is induced by host cells.","date":"2013","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23897607","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16904387","id":"PMC_16904387","title":"Replication arrest-stimulated recombination: Dependence on the RecA paralog, RadA/Sms and translesion polymerase, DinB.","date":"2006","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/16904387","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2138476","id":"PMC_2138476","title":"Percoll density gradient centrifugation of rat pituitary tumor cells: a study of functional heterogeneity within and between tumors with respect to growth rates, prolactin production and responsiveness to the somatostatin analog SMS 201-995.","date":"1990","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/2138476","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19482879","id":"PMC_19482879","title":"Short message service (SMS) technology in alcohol research--a feasibility study.","date":"2009","source":"Alcohol and alcoholism (Oxford, Oxfordshire)","url":"https://pubmed.ncbi.nlm.nih.gov/19482879","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2888549","id":"PMC_2888549","title":"Effect of SMS 201-995, a long-acting somatostatin analogue, on the secretion and morphology of a pituitary growth hormone cell adenoma.","date":"1987","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/2888549","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34312488","id":"PMC_34312488","title":"N6-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34312488","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18285828","id":"PMC_18285828","title":"How much is too much? Phenotypic consequences of Rai1 overexpression in mice.","date":"2008","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/18285828","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19206178","id":"PMC_19206178","title":"A missense mutation, p.V132G, in the X-linked spermine synthase gene (SMS) causes Snyder-Robinson syndrome.","date":"2009","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/19206178","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24248037","id":"PMC_24248037","title":"A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message service (SMS) via the mobile phone.","date":"2013","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24248037","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7982482","id":"PMC_7982482","title":"Somatostatin receptor subtype SSTR2 mediates the inhibition of high-voltage-activated calcium channels by somatostatin and its analogue SMS 201-995.","date":"1994","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7982482","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26366885","id":"PMC_26366885","title":"Stating Appointment Costs in SMS Reminders Reduces Missed Hospital Appointments: Findings from Two Randomised Controlled Trials.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26366885","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21398530","id":"PMC_21398530","title":"Regulation of cytotoxicity by quorum-sensing signaling in Vibrio vulnificus is mediated by SmcR, a repressor of hlyU.","date":"2011","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/21398530","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21545756","id":"PMC_21545756","title":"Smith-Magenis syndrome: haploinsufficiency of RAI1 results in altered gene regulation in neurological and metabolic pathways.","date":"2011","source":"Expert reviews in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21545756","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12837267","id":"PMC_12837267","title":"Molecular cloning and characterization of human RAI1, a gene associated with schizophrenia.","date":"2003","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/12837267","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21629438","id":"PMC_21629438","title":"Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior.","date":"2010","source":"Current genomics","url":"https://pubmed.ncbi.nlm.nih.gov/21629438","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18579523","id":"PMC_18579523","title":"A consensus sequence for binding of SmcR, a Vibrio vulnificus LuxR homologue, and genome-wide identification of the SmcR regulon.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18579523","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18051765","id":"PMC_18051765","title":"Identification and functional analysis of vibrio vulnificus SmcR, a novel global regulator.","date":"2007","source":"Journal of microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/18051765","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17041942","id":"PMC_17041942","title":"RAI1 point mutations, CAG repeat variation, and SNP analysis in non-deletion Smith-Magenis syndrome.","date":"2006","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/17041942","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26845522","id":"PMC_26845522","title":"Recombinational branch migration by the RadA/Sms paralog of RecA in Escherichia coli.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26845522","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2702445","id":"PMC_2702445","title":"Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy.","date":"1989","source":"The British journal of surgery","url":"https://pubmed.ncbi.nlm.nih.gov/2702445","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2888550","id":"PMC_2888550","title":"A comparison between the effects of SMS 201-995, bromocriptine and a combination of both drugs on hormone release by the cultured pituitary tumour cells of acromegalic patients.","date":"1987","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/2888550","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30919975","id":"PMC_30919975","title":"Importance of OsRac1 and RAI1 in signalling of nucleotide-binding site leucine-rich repeat protein-mediated resistance to rice blast disease.","date":"2019","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/30919975","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20178981","id":"PMC_20178981","title":"Crystal structure of SmcR, a quorum-sensing master regulator of Vibrio vulnificus, provides insight into its regulation of transcription.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20178981","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29138588","id":"PMC_29138588","title":"RAI1 gene mutations: mechanisms of Smith-Magenis syndrome.","date":"2017","source":"The application of clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29138588","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21857958","id":"PMC_21857958","title":"Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21857958","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16971386","id":"PMC_16971386","title":"Transcriptional regulatory cascade for elastase production in Vibrio vulnificus: LuxO activates luxT expression and LuxT represses smcR expression.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16971386","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32374864","id":"PMC_32374864","title":"DXO/Rai1 enzymes remove 5'-end FAD and dephospho-CoA caps on RNAs.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32374864","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17273973","id":"PMC_17273973","title":"Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all null alleles are alike.","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17273973","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23716618","id":"PMC_23716618","title":"The fur-iron complex modulates expression of the quorum-sensing master regulator, SmcR, to control expression of virulence factors in Vibrio vulnificus.","date":"2013","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23716618","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2461665","id":"PMC_2461665","title":"SMS 201-995 and provocation tests in preparation of patients with carcinoids for surgery or hepatic arterial embolization.","date":"1988","source":"Anesthesia and analgesia","url":"https://pubmed.ncbi.nlm.nih.gov/2461665","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26544804","id":"PMC_26544804","title":"Nonrecurrent 17p11.2p12 Rearrangement Events that Result in Two Concomitant Genomic Disorders: The PMP22-RAI1 Contiguous Gene Duplication Syndrome.","date":"2015","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26544804","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23028815","id":"PMC_23028815","title":"RAI1 transcription factor activity is impaired in mutants associated with Smith-Magenis Syndrome.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23028815","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20110369","id":"PMC_20110369","title":"Direct interaction between quorum-sensing regulator SmcR and RNA polymerase is mediated by integration host factor to activate vvpE encoding elastase in Vibrio vulnificus.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20110369","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32783930","id":"PMC_32783930","title":"RAI1 Regulates Activity-Dependent Nascent Transcription and Synaptic Scaling.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32783930","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20738874","id":"PMC_20738874","title":"Functional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis Syndrome.","date":"2010","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20738874","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12446025","id":"PMC_12446025","title":"The apoptotic effect of somatostatin analogue SMS 201-995 on human lymphocytes.","date":"2002","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/12446025","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25781356","id":"PMC_25781356","title":"Whole exome sequencing identifies RAI1 mutation in a morbidly obese child diagnosed with ROHHAD syndrome.","date":"2015","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25781356","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2361474","id":"PMC_2361474","title":"Effects of SMS 201-995 on basal and stimulated pancreatic secretion in rats.","date":"1990","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/2361474","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11404004","id":"PMC_11404004","title":"RAI1 is a novel polyglutamine encoding gene that is deleted in Smith-Magenis syndrome patients.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11404004","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15690371","id":"PMC_15690371","title":"Diagnostic FISH probes for del(17)(p11.2p11.2) associated with Smith-Magenis syndrome should contain the RAI1 gene.","date":"2005","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/15690371","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24878353","id":"PMC_24878353","title":"Retinoic acid induced-1 (Rai1) regulates craniofacial and brain development in Xenopus.","date":"2014","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/24878353","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33328610","id":"PMC_33328610","title":"Implementation of a 4Pi-SMS super-resolution microscope.","date":"2020","source":"Nature protocols","url":"https://pubmed.ncbi.nlm.nih.gov/33328610","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28821288","id":"PMC_28821288","title":"Health promotion via SMS improves hypertension knowledge for deaf South Africans.","date":"2017","source":"BMC public health","url":"https://pubmed.ncbi.nlm.nih.gov/28821288","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25032960","id":"PMC_25032960","title":"Pharmacologic inhibition of sphingomyelin synthase (SMS) activity reduces apolipoprotein-B secretion from hepatocytes and attenuates endotoxin-mediated macrophage inflammation.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25032960","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30275311","id":"PMC_30275311","title":"Early adolescent Rai1 reactivation reverses transcriptional and social interaction deficits in a mouse model of Smith-Magenis syndrome.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30275311","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22679105","id":"PMC_22679105","title":"Evidence that the Vibrio vulnificus flagellar regulator FlhF is regulated by a quorum sensing master regulator SmcR.","date":"2012","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22679105","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8124483","id":"PMC_8124483","title":"Effect of bromocriptine and SMS 201-995 on growth of human somatotrophic and non-functioning pituitary adenoma cells in vitro.","date":"1994","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8124483","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24932451","id":"PMC_24932451","title":"Frequency of De Quervain's tenosynovitis and its association with SMS texting.","date":"2014","source":"Muscles, ligaments and tendons journal","url":"https://pubmed.ncbi.nlm.nih.gov/24932451","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2105279","id":"PMC_2105279","title":"The effect of the E2 prostaglandin enprostil, and the somatostatin analogue SMS 201 995, on the growth of a human gastric cell line, MKN45G.","date":"1990","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/2105279","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2454125","id":"PMC_2454125","title":"The effect of a somatostatin analogue (SMS 201-995, Sandostatin) on the concentration of phosphoribosyl pyrophosphate and the activity of the pentose phosphate pathway in the early renal hypertrophy of experimental diabetes in the rat.","date":"1988","source":"Biochemical medicine and metabolic biology","url":"https://pubmed.ncbi.nlm.nih.gov/2454125","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27799067","id":"PMC_27799067","title":"Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomics.","date":"2016","source":"Genome medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27799067","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23703963","id":"PMC_23703963","title":"Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1.","date":"2013","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/23703963","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28511132","id":"PMC_28511132","title":"Activity and in vivo dynamics of Bacillus subtilis DisA are affected by RadA/Sms and by Holliday junction-processing proteins.","date":"2017","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/28511132","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2879448","id":"PMC_2879448","title":"Characterization of the in vivo and in vitro inhibition of gastrin secretion from gastrinoma by a somatostatin analogue (SMS 201-995).","date":"1986","source":"The American journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2879448","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36089128","id":"PMC_36089128","title":"Variation in community structure and network characteristics of spent mushroom substrate (SMS) compost microbiota driven by time and environmental conditions.","date":"2022","source":"Bioresource technology","url":"https://pubmed.ncbi.nlm.nih.gov/36089128","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2568572","id":"PMC_2568572","title":"Changes in expression of tyrosine hydroxylase immunoreactivity in human SMS-KCNR neuroblastoma following retinoic acid or phorbol ester-induced differentiation.","date":"1989","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/2568572","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19277733","id":"PMC_19277733","title":"The impact of spermine synthase (SMS) mutations on brain morphology.","date":"2009","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19277733","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31350886","id":"PMC_31350886","title":"Bacillus subtilis RecA interacts with and loads RadA/Sms to unwind recombination intermediates during natural chromosomal transformation.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31350886","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31580924","id":"PMC_31580924","title":"The complete loss of function of the SMS gene results in a severe form of Snyder-Robinson syndrome.","date":"2019","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31580924","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24715852","id":"PMC_24715852","title":"Identification of Nine New RAI1-Truncating Mutations in Smith-Magenis Syndrome Patients without 17p11.2 Deletions.","date":"2014","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/24715852","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38358362","id":"PMC_38358362","title":"CuO/TiO2/MXene-Based Sensor and SMS-TENG Array Integrated Inspection Robots for Self-Powered Ethanol Detection and Alarm at Room Temperature.","date":"2024","source":"ACS sensors","url":"https://pubmed.ncbi.nlm.nih.gov/38358362","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26101253","id":"PMC_26101253","title":"Structural and biochemical studies of the distinct activity profiles of Rai1 enzymes.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26101253","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24205348","id":"PMC_24205348","title":"A phylogenetic study of SPBP and RAI1: evolutionary conservation of chromatin binding modules.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24205348","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7830057","id":"PMC_7830057","title":"Coupling of the human Y2 receptor for neuropeptide Y and peptide YY to guanine nucleotide inhibitory proteins in permeabilized SMS-KAN cells.","date":"1995","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7830057","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37994247","id":"PMC_37994247","title":"Pentanucleotide Repeat Insertions in RAI1 Cause Benign Adult Familial Myoclonic Epilepsy Type 8.","date":"2023","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/37994247","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25056061","id":"PMC_25056061","title":"Biological insights from 108 schizophrenia-associated genetic loci.","date":"2014","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/25056061","citation_count":5878,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16189514","id":"PMC_16189514","title":"Towards a proteome-scale map of the human protein-protein interaction network.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16189514","citation_count":2090,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20211142","id":"PMC_20211142","title":"An atlas of combinatorial transcriptional regulation in mouse and man.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/20211142","citation_count":573,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21738487","id":"PMC_21738487","title":"Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease.","date":"2011","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21738487","citation_count":422,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28611215","id":"PMC_28611215","title":"Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28611215","citation_count":282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24262325","id":"PMC_24262325","title":"Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants.","date":"2013","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/24262325","citation_count":269,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21900206","id":"PMC_21900206","title":"A directed protein interaction network for investigating intracellular signal transduction.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21900206","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25281560","id":"PMC_25281560","title":"Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.","date":"2014","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/25281560","citation_count":215,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30804502","id":"PMC_30804502","title":"H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30804502","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32344865","id":"PMC_32344865","title":"Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32344865","citation_count":146,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22586326","id":"PMC_22586326","title":"Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.","date":"2012","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/22586326","citation_count":145,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30154076","id":"PMC_30154076","title":"SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.","date":"2018","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/30154076","citation_count":124,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11347906","id":"PMC_11347906","title":"Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.","date":"2001","source":"DNA research : an international journal for rapid publication of reports on genes and genomes","url":"https://pubmed.ncbi.nlm.nih.gov/11347906","citation_count":123,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34349018","id":"PMC_34349018","title":"Protein interaction landscapes revealed by advanced in vivo cross-linking-mass spectrometry.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34349018","citation_count":113,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31753913","id":"PMC_31753913","title":"Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/31753913","citation_count":110,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30021884","id":"PMC_30021884","title":"Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry in Intact Cell Nuclei.","date":"2018","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/30021884","citation_count":101,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35013218","id":"PMC_35013218","title":"EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35013218","citation_count":99,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15788730","id":"PMC_15788730","title":"RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions.","date":"2005","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15788730","citation_count":91,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28977666","id":"PMC_28977666","title":"CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28977666","citation_count":91,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48561,"output_tokens":3673,"usd":0.100389},"stage2":{"model":"claude-opus-4-6","input_tokens":7097,"output_tokens":3111,"usd":0.16989},"total_usd":0.753896,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":61871,"output_tokens":7491,"usd":0.148989},"round2_rules_fired":"R2","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9127,"output_tokens":7098,"usd":0.334628}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Dominant frameshift mutations in RAI1 leading to protein truncation cause Smith-Magenis syndrome features in individuals without 17p11.2 deletions, establishing RAI1 haploinsufficiency as the causal mechanism for SMS.\",\n      \"method\": \"Sanger sequencing of RAI1 in non-deletion SMS patients; identification of de novo frameshift mutations\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational mutation identification replicated across multiple subsequent studies\",\n      \"pmids\": [\"12652298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RAI1 encodes a protein containing a zinc finger-like plant homeodomain (PHD) at the carboxyl terminus conserved in the trithorax group of chromatin-based transcription regulators, suggesting RAI1 is involved in transcriptional control through a multi-protein complex.\",\n      \"method\": \"Bioinformatics analysis of RAI1 mutations in non-deletion SMS patients; comparative genomics between human and mouse orthologues\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — computational domain prediction with functional inference from mutation data\",\n      \"pmids\": [\"15565467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Rai1 is localized to the nucleus and has transactivation activity, as demonstrated by GFP and GAL4-DNA binding domain fusions; Rai1 haploinsufficiency causes obesity and craniofacial abnormalities in mice, and homozygous loss causes lethality during gastrulation.\",\n      \"method\": \"Gene targeting to generate null allele with lacZ reporter; nuclear localization by GFP fusion; transactivation by GAL4-fusion assay; phenotypic analysis of Rai1+/- and Rai1-/- mice\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO mouse with defined phenotypes, nuclear localization and transactivation demonstrated by direct experiment\",\n      \"pmids\": [\"15746153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Rai1 gene copy number (duplication) is the dosage-sensitive genetic cause of Potocki-Lupski syndrome phenotypes; normalization of Rai1 to two copies rescued complex physical and behavioral phenotypes in Dp(11)17/Rai1(-) compound heterozygous mice despite trisomic dosage of the other 18 genes in the interval.\",\n      \"method\": \"Genetic epistasis using compound heterozygous mice with duplication on one chromosome and null allele on the other; behavioral and physical phenotyping\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic epistasis with defined cellular/organismal phenotype readout\",\n      \"pmids\": [\"17024248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Rai1 is predominantly expressed in neurons of the hippocampus and cerebellum; Rai1-/- mice display motor impairment, seizures, and learning deficits, while Rai1+/- mice show abnormal EEG, establishing Rai1 as a dosage-sensitive gene critical for central nervous system function.\",\n      \"method\": \"X-gal staining for Rai1 expression in Rai1+/- mice; behavioral battery including locomotor activity, EEG recording, and context/tone-dependent learning tests\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional consequence; clean KO with multiple defined phenotypes\",\n      \"pmids\": [\"17517686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RAI1 protein localizes to the nucleus and activates transcription; frameshift mutations generating N-terminal truncations produce cytoplasmic mislocalized protein with no transcriptional activation of the BDNF enhancer, while missense mutations at the C-terminus show nuclear localization but no transactivation, demonstrating that transcription factor activity and nuclear localization signals reside in separate domains.\",\n      \"method\": \"Immunofluorescence for subcellular localization; luciferase reporter assay for transactivation; western blot; analysis of full-length and truncated RAI1 constructs\",\n      \"journal\": \"BMC molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (localization, transactivation assay) in same study with defined functional consequences\",\n      \"pmids\": [\"20738874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RAI1 acts as a positive transcriptional regulator of CLOCK, a key circadian oscillator component; haploinsufficiency of RAI1 in SMS patient fibroblasts and mouse hypothalamus results in transcriptional dysregulation of multiple circadian genes including PER2, PER3, CRY1, and BMAL1.\",\n      \"method\": \"Reporter assays for CLOCK promoter activity; RT-PCR and qPCR of circadian gene expression in SMS fibroblasts and Rai1+/- mouse hypothalamus; chromatin studies\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct transcriptional regulation demonstrated by promoter assay plus loss-of-function in both human cells and mouse model\",\n      \"pmids\": [\"22578325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RAI1 truncating mutations result in cytoplasmic mislocalization of the protein and loss of transcriptional activation through an endogenous target (BDNF enhancer); in lymphoblastoid cells from an SMS patient with RAI1 c.3103insC, the wild-type RAI1 product is found in chromatin-bound and nuclear matrix fractions while the mutant product is mainly cytoplasmic.\",\n      \"method\": \"Subcellular fractionation; immunofluorescence; luciferase reporter assay; analysis of patient-derived lymphoblastoid cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including patient-derived cell fractionation and reporter assay\",\n      \"pmids\": [\"23028815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The circadian free-running period is shortened in Rai1+/- mice, establishing Rai1 as a primary gene underlying circadian defects in Smith-Magenis syndrome.\",\n      \"method\": \"Free-running period length analysis in Rai1+/- and Df(11)17-2/+ mice using circadian activity monitoring\",\n      \"journal\": \"American journal of medical genetics. Part A\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined circadian phenotype readout in single study\",\n      \"pmids\": [\"23703963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RAI1 contains conserved chromatin-binding modules including a C-terminal ePHD/ADD-like domain that adopts a cross-braced zinc finger topology, and a novel nucleosome binding region that directly binds the nucleosome core and histones in vitro.\",\n      \"method\": \"Phylogenetic analysis; in vitro binding studies of RAI1 nucleosome binding region with nucleosome core and histones; interaction studies in yeast cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — in vitro binding demonstrated, structural topology inferred by analogy\",\n      \"pmids\": [\"24205348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Knockdown of Rai1 in Xenopus causes midface hypoplasia, malformed mouth, aberrant neural crest migration, reduced facial cartilage, abnormal axon patterns, decreased forebrain ventricle size, decreased bdnf, and increased forebrain apoptosis, establishing Rai1 as required for normal neural and craniofacial development.\",\n      \"method\": \"Antisense morpholino knockdown in Xenopus laevis/tropicalis; in situ hybridization; phenotypic analysis of craniofacial and brain development\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with multiple defined developmental phenotype readouts in vertebrate model\",\n      \"pmids\": [\"24878353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Rai1 preferentially occupies DNA regions near active promoters genome-wide and promotes expression of genes involved in circuit assembly and neuronal communication; pan-neural loss causes deficits in motor function, learning, and food intake; loss in inhibitory neurons or subcortical glutamatergic neurons causes learning deficits; loss in Sim1+ or SF1+ cells causes obesity.\",\n      \"method\": \"ChIP-seq for Rai1 occupancy; conditional knockout in specific neuronal populations; behavioral phenotyping for motor function, learning, and food intake\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-seq plus cell-type-specific conditional KO with multiple defined phenotypic readouts in same study\",\n      \"pmids\": [\"27693255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Normalizing Rai1 levels 3–4 weeks after birth (early adolescence) corrects expression of genes related to neural developmental pathways and fully reverses a social interaction deficit caused by Rai1 haploinsufficiency; Rai1 reactivation at 7–8 weeks is not beneficial. Rai1 is required in both excitatory and inhibitory neurons for proper social interactions. Rai1 heterozygous mice show reduced dendritic spines in medial prefrontal cortex.\",\n      \"method\": \"Conditional genetic Rai1 reactivation at defined postnatal time points; RNA-seq transcriptomics; behavioral testing; spine density analysis; optogenetic activation of mPFC\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — temporal genetic rescue with transcriptomic and behavioral endpoints in same study\",\n      \"pmids\": [\"30275311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RAI1 suppresses synaptic upscaling in the naive neuronal network while promoting upscaling triggered by activity silencing; RAI1 dynamically occupies chromatin in response to network activity shifts and regulates nascent transcription of ~45% of expressed genes during activity-dependent transcriptional reprogramming.\",\n      \"method\": \"Nascent RNA sequencing (EU-seq); dynamic ChIP-seq for RAI1 occupancy; electrophysiological recording of mEPSC amplitude (synaptic scaling) in Rai1-deficient neurons\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (nascent RNA-seq, ChIP-seq, electrophysiology) in same study\",\n      \"pmids\": [\"32783930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RAI1 enhances transcription of Hippo pathway upstream genes by binding to their 3'UTR and suppresses YAP/TAZ nuclear translocation; RAI1 is the main target of miR-194-2 in esophageal cancer, which is regulated by ALKBH5-mediated m6A demethylation of pri-miR-194-2.\",\n      \"method\": \"RNA-IP/binding assays; luciferase reporter assay; western blot for YAP/TAZ localization; miRNA target validation; cell and animal models\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — binding to 3'UTR and pathway placement demonstrated but some methods not fully detailed in abstract\",\n      \"pmids\": [\"34312488\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Intronic TTTCA pentanucleotide repeat insertions in RAI1 (intron 4) cause benign adult familial myoclonic epilepsy type 8 (BAFME8); RAI1 mRNA levels in affected individuals are not different from controls, suggesting haploinsufficiency is not the pathomechanism.\",\n      \"method\": \"Long-read whole genome sequencing; repeat-primed PCR; RNA quantification in patient leukocytes\",\n      \"journal\": \"Movement disorders\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — molecular identification with RNA expression analysis, but mechanism of repeat toxicity not fully established\",\n      \"pmids\": [\"37994247\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RAI1 is a dosage-sensitive nuclear transcription factor that occupies active gene promoters genome-wide, contains chromatin reader modules (ePHD/ADD-like zinc finger and nucleosome-binding domain), directly transactivates target genes including CLOCK and BDNF, regulates activity-dependent nascent transcription and synaptic scaling in neurons, and controls circadian rhythmicity, craniofacial/neural development, and energy homeostasis through cell-type-specific functions in distinct neuronal populations; haploinsufficiency of RAI1 causes Smith-Magenis syndrome by reducing transcription factor activity, with truncating mutations mislocalizing the protein to the cytoplasm and missense mutations in the C-terminal domain abolishing transactivation despite preserved nuclear localization.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper before extracting discoveries.\n\n**Classification decisions:**\n\nPapers about RAI1 (human retinoic acid induced 1 gene, chromosome 17p11.2): KEEP\n- [2] RAI1 mutations in SMS — KEEP\n- [6] Structure of Rat1/Rai1 (yeast ortholog) — KEEP (ortholog, foundational mechanism)\n- [14] S. cerevisiae RAI1/Rai1p — KEEP (ortholog)\n- [18] RAI1 PHD domain mutations — KEEP\n- [20] RAI1 regulates CLOCK — KEEP\n- [23] CAG repeat in RAI1, SCA2 — borderline (GWAS association), EXCLUDE (no mechanism)\n- [24] Rai1 mouse knockout — KEEP\n- [27] Rai1 behavioral mouse model — KEEP\n- [32] Rai1 duplication mouse — KEEP\n- [34] Molecular/neural functions of Rai1 — KEEP\n- [35] RAI1 nonsense mutation — KEEP (clinical/functional)\n- [41] ALKBH5/miR-194-2/RAI1 axis — KEEP (RAI1 as target, mechanistic role described)\n- [42] Rai1 overexpression mice — KEEP\n- [48] SMS/RAI1 haploinsufficiency review — KEEP (review with mechanistic content)\n- [49] Human RAI1 cloning/characterization — KEEP\n- [50] RAI1 dosage review — KEEP\n- [53] RAI1 mutations/CAG — KEEP\n- [59] RAI1 mutations/SMS mechanisms review — KEEP\n- [60] RAI1 molecular analysis — KEEP\n- [62] DXO/Rai1 enzymes, FAD/CoA caps — KEEP (ortholog mechanism)\n- [63] Rai1 penetrance in mice — KEEP\n- [67] RAI1 transcription factor activity — KEEP\n- [69] RAI1 activity-dependent transcription/synaptic scaling — KEEP\n- [70] RAI1 mutations functional characterization — KEEP\n- [72] RAI1 mutation in obese child — KEEP (de novo mutation)\n- [74] RAI1 cloning, polyglutamine — KEEP\n- [76] Rai1 in Xenopus development — KEEP (ortholog)\n- [80] Rai1 reactivation in mice — KEEP\n- [86] RAI1-associated disease network — KEEP\n- [87] Circadian abnormalities, RAI1 — KEEP\n- [95] RAI1 truncating mutations — KEEP\n- [97] Structural/biochemical studies of Rai1 enzymes — KEEP (yeast/fungal ortholog)\n- [98] SPBP and RAI1 phylogenetic/chromatin binding — KEEP\n- [100] Pentanucleotide repeats in RAI1, BAFME8 — KEEP\n\nPapers about other genes/topics named SMS or SmcR or RadA/Sms: EXCLUDE\n- [1] SSTR1-5 somatostatin receptors — EXCLUDE (alias collision: SMS = octreotide)\n- [3] SMS reminder adherence asthma — EXCLUDE (SMS = short message service)\n- [4] Sandostatin/SMS 201-995 — EXCLUDE\n- [5] CARDS SMS diabetes — EXCLUDE\n- [7] SMS 201-995 acromegaly — EXCLUDE\n- [8] Spermine synthase SMS gene — EXCLUDE (alias collision: SMS = spermine synthase)\n- [9] Sphingomyelin synthase SMS — EXCLUDE (alias collision)\n- [10] SMS 201-995 antiproliferative — EXCLUDE\n- [11] SMS reminders Uganda — EXCLUDE\n- [12] Sphingomyelin synthase SMS — EXCLUDE\n- [13] SMS 201-995 amino acids — EXCLUDE\n- [15] SMS 201-995 pancreatic — EXCLUDE\n- [16] radA/sms E. coli — EXCLUDE (bacterial gene)\n- [17] SMS 201-995 islet cell — EXCLUDE\n- [19] SmcR Vibrio vulnificus — EXCLUDE (bacterial)\n- [21] p27Kip1 in SMS-KCNR cells — EXCLUDE (SMS-KCNR is a neuroblastoma cell line, not about RAI1)\n- [22] SMS-REPs structure — borderline; this is about Smith-Magenis syndrome genomic region but no RAI1 mechanism — EXCLUDE (structural genomics, no RAI1 mechanism)\n- [25] Cell phone SMS HIV — EXCLUDE\n- [26] SMS-EC spectroelectrochemistry — EXCLUDE\n- [28] RAI1 sleep apnea GWAS — EXCLUDE (GWAS association only)\n- [29] bHLH RAI1 rice immunity — EXCLUDE (symbol collision: rice RAI1 = different gene)\n- [30] SMS 201-995 PTP1C — EXCLUDE\n- [31] SMS 201-995 plasma protein — EXCLUDE\n- [33] SMS domain sphingomyelin synthase — EXCLUDE\n- [36] SmcR Vibrio — EXCLUDE\n- [37] RadA/Sms E. coli — EXCLUDE\n- [38] SMS 201-995 pituitary — EXCLUDE\n- [39] SMS alcohol research — EXCLUDE\n- [40] SMS 201-995 pituitary adenoma — EXCLUDE\n- [43] Spermine synthase SMS missense — EXCLUDE\n- [44] SMS allergy adherence — EXCLUDE\n- [45] SMS 201-995 Ca2+ channels — EXCLUDE\n- [46] SMS appointment reminders — EXCLUDE\n- [47] SmcR Vibrio cytotoxicity — EXCLUDE\n- [51] SmcR consensus — EXCLUDE\n- [52] SmcR Vibrio — EXCLUDE\n- [53] RAI1 CAG repeat — KEEP (already noted)\n- [54] RadA/Sms branch migration — EXCLUDE (bacterial)\n- [55] SMS 201-995 dumping — EXCLUDE\n- [56] SMS 201-995 bromocriptine — EXCLUDE\n- [57] Rice RAI1/OsRac1 — EXCLUDE (symbol collision: rice)\n- [58] SmcR crystal structure — EXCLUDE\n- [59] already classified KEEP\n- [60] already classified KEEP\n- [61] SmcR Vibrio — EXCLUDE\n- [64] SmcR Fur — EXCLUDE\n- [65] SMS 201-995 carcinoids — EXCLUDE\n- [66] PMP22-RAI1 duplication — KEEP (mentions RAI1 dosage sensitivity, but primarily genomic/clinical)... actually contains mechanistic statement about RAI1 dosage sensitivity — KEEP for dosage finding\n- [68] SmcR Vibrio — EXCLUDE\n- [71] SMS 201-995 lymphocytes — EXCLUDE\n- [73] SMS 201-995 pancreatic rats — EXCLUDE\n- [75] FISH probes RAI1 — EXCLUDE (diagnostic)\n- [77] 4Pi-SMS microscopy — EXCLUDE\n- [78] SMS health promotion — EXCLUDE\n- [79] Sphingomyelin synthase SMS — EXCLUDE\n- [81] SmcR flagellar — EXCLUDE\n- [82] SMS 201-995 bromocriptine adenoma — EXCLUDE\n- [83] SMS texting De Quervain — EXCLUDE\n- [84] SMS 201-995 gastric — EXCLUDE\n- [85] SMS 201-995 diabetes — EXCLUDE\n- [86] already KEEP\n- [87] already KEEP\n- [88] RadA/Sms Bacillus — EXCLUDE (bacterial)\n- [89] SMS 201-995 gastrinoma — EXCLUDE\n- [90] SMS compost — EXCLUDE\n- [91] SMS-KCNR neuroblastoma retinoic acid — EXCLUDE (SMS-KCNR is a cell line name, not about RAI1 gene mechanism)\n- [92] Spermine synthase SMS brain — EXCLUDE\n- [93] RadA/Sms Bacillus transformation — EXCLUDE\n- [94] Spermine synthase SMS complete loss — EXCLUDE\n- [96] SMS-TENG sensor — EXCLUDE\n- [99] SMS-KAN neuroblastoma Y2 receptor — EXCLUDE (SMS-KAN is a cell line)\n\n**Additional curated papers:**\n- [gene2pubmed 29] RAI1 variations SMS — KEEP\n- Others: mostly interactome/proteomics screens, GWAS, not specifically mechanistic for RAI1 — EXCLUDE unless RAI1-specific mechanism found\n\nNow extracting discoveries from KEPT papers:\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"S. cerevisiae Rai1p (YGL246c) physically binds the nuclear 5'→3' exoribonuclease Rat1p and stabilizes its in vitro exoribonuclease activity. Deletion of RAI1 is synthetically lethal with the rat1-1(ts) mutation, placing Rai1p as a functional partner of Rat1p in nuclear RNA processing and 5.8S rRNA maturation.\",\n      \"method\": \"Yeast two-hybrid, co-purification, in vitro exoribonuclease assay, genetic epistasis (synthetic lethality), Northern blot rRNA analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal genetic and biochemical evidence (purified protein stimulation assay + synthetic lethality + rRNA processing phenotype) in a single rigorous study\",\n      \"pmids\": [\"10805743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"RAI1 encodes a nuclear protein highly expressed in neuronal tissues; the human gene comprises six exons producing a 7.6-kb mRNA and contains a polymorphic CAG repeat coding for a polyglutamine stretch in the N-terminal domain.\",\n      \"method\": \"cDNA cloning, RT-PCR expression profiling, genomic sequencing\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct molecular characterization but no functional assay beyond expression; single study\",\n      \"pmids\": [\"12837267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Dominant frameshift mutations causing protein truncation in RAI1 are sufficient to produce Smith-Magenis syndrome features in the absence of 17p11.2 deletions, establishing RAI1 haploinsufficiency as the molecular basis for SMS.\",\n      \"method\": \"Sequencing of RAI1 in non-deletion SMS patients; frameshift mutation identification\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple independent patients with truncating mutations, replicated by subsequent studies; foundational genetic finding\",\n      \"pmids\": [\"12652298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Bioinformatics analysis of RAI1 protein sequence identified a conserved zinc finger-like plant homeodomain (PHD) at the C-terminus, homologous to trithorax-group chromatin-based transcription regulators, suggesting RAI1 functions in transcriptional control through a multi-protein chromatin-regulatory complex.\",\n      \"method\": \"Bioinformatics/comparative genomics (human–mouse ortholog alignment); PHD domain identification\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational prediction; no direct functional assay of PHD domain in this study\",\n      \"pmids\": [\"15565467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Heterozygous Rai1 null mice (generated by gene targeting with lacZ insertion) recapitulate SMS features including obesity and craniofacial abnormalities. GFP-Rai1 fusion protein localizes to the nucleus and the GAL4-Rai1 fusion has transactivation activity, demonstrating that Rai1 is a nuclear transcriptional activator.\",\n      \"method\": \"Gene targeting/knockout mice, X-gal staining, GFP subcellular localization, GAL4 transactivation reporter assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct transactivation assay + nuclear localization experiment + in vivo knockout phenotype; multiple orthogonal methods\",\n      \"pmids\": [\"15746153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Restoring normal disomic Rai1 dosage in Dp(11)17/+ mice by combining the duplication with a Rai1 null allele rescues the complex physical and behavioral phenotypes, demonstrating that RAI1 copy number is the primary dosage-sensitive determinant of both SMS and dup(17)(p11.2) phenotypes.\",\n      \"method\": \"Compound heterozygous mouse genetics; behavioral and physical phenotyping of Dp(11)17/Rai1(-) mice\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue experiment with defined single-gene dosage manipulation; strong phenotypic rescue\",\n      \"pmids\": [\"17024248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Rai1 homozygous null mice display severe learning and motor deficits, hind limb clasping, overt seizures, and context/tone-dependent learning deficits. X-gal staining reveals Rai1 is predominantly expressed in hippocampal and cerebellar neurons, and Rai1 functions in a dosage-sensitive manner in the CNS.\",\n      \"method\": \"Behavioral testing battery (locomotion, EEG, context/tone fear conditioning), X-gal staining of Rai1+/- brain sections\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with specific neurological phenotypic readouts + direct localization by reporter staining\",\n      \"pmids\": [\"17517686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Rai1-transgenic mice overexpressing Rai1 >1.5-fold show growth retardation, increased locomotor activity, abnormal anxiety behavior, altered gait, decreased grip strength, and dominant social behavior; homozygous transgenic mice show dosage-dependent exacerbation including severe neurological deficits, confirming that RAI1 operates with strict dosage thresholds for normal development.\",\n      \"method\": \"Transgenic mouse overexpression (hemizygous and homozygous), behavioral phenotyping, grip strength, gait analysis\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — dose-response genetic experiment with multiple phenotypic readouts; replicates dosage sensitivity concept\",\n      \"pmids\": [\"18285828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structures of S. pombe Rat1 in complex with Rai1 (2.2 Å), and of Rai1 and murine Dom3Z alone (2.0 Å) reveal the molecular mechanism by which Rai1 activates Rat1 exoribonuclease activity and enables Rat1 to degrade RNAs with stable secondary structures. A conserved active-site pocket in Rai1/Dom3Z with three acidic residues coordinates a divalent cation; mutagenesis and biochemical assays demonstrate that Rai1 possesses pyrophosphohydrolase activity toward 5′-triphosphorylated RNA — the first demonstration of this activity in eukaryotes.\",\n      \"method\": \"X-ray crystallography, in vitro exoribonuclease assay, pyrophosphohydrolase activity assay, active-site mutagenesis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure at 2.0–2.2 Å + mutagenesis + multiple biochemical assays; single rigorous paper with orthogonal methods\",\n      \"pmids\": [\"19194460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Full-length human RAI1 protein localizes to the nucleus and activates transcription of a reporter gene. Frameshift truncation mutations (N-terminal half) cause cytoplasmic mislocalization and loss of transactivation of BDNF enhancer; missense mutations in the C-terminal half retain nuclear localization but abolish transactivation. Transcription factor activity and nuclear localization signals reside in distinct protein domains.\",\n      \"method\": \"Western blot, immunofluorescence localization, luciferase reporter transactivation assay with wild-type and mutant RAI1 constructs\",\n      \"journal\": \"BMC molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple domain-deletion/mutation constructs with orthogonal localization and transactivation readouts; replicated in patient lymphoblastoid cells\",\n      \"pmids\": [\"20738874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RAI1 directly regulates transcription of CLOCK, a master circadian oscillator gene. Haploinsufficiency of RAI1 in SMS patient fibroblasts and Rai1+/- mouse hypothalamus disrupts circadian clock gene expression including PER2, PER3, CRY1, and BMAL1, demonstrating RAI1 as a positive transcriptional regulator of CLOCK and a critical component of the mammalian circadian oscillator.\",\n      \"method\": \"Luciferase promoter reporter assay (CLOCK promoter), RT-qPCR of circadian genes in patient fibroblasts and mouse hypothalamus, circadian gene expression profiling\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct promoter assay combined with patient cell and mouse tissue validation; multiple circadian gene targets measured; replicated across cell and animal models\",\n      \"pmids\": [\"22578325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SMS patient-derived lymphoblastoid cells carrying RAI1 c.3103insC mutation show the mutant truncated protein in cytoplasmic fractions while wild-type RAI1 localizes to chromatin-bound and nuclear matrix fractions, confirming that N-terminal truncations of RAI1 displace the protein from chromatin and abolish BDNF enhancer-directed transactivation.\",\n      \"method\": \"Subcellular fractionation (chromatin-bound, nuclear matrix, cytoplasmic), immunoblot, BDNF-luciferase reporter in patient lymphoblastoid cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — subcellular fractionation with functional consequence (transactivation loss) validated in patient-derived cells\",\n      \"pmids\": [\"23028815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RAI1 protein contains a C-terminal ePHD/ADD-like chromatin-binding domain and a novel nucleosome-binding region (NBR) that is highly conserved in vertebrates. In vitro and yeast experiments show the ePHD/ADD-like domain adopts a cross-braced zinc finger topology. The conserved NBR of RAI1 directly binds the nucleosome core and histones.\",\n      \"method\": \"In vitro pull-down (nucleosome core binding), yeast two-hybrid, phylogenetic/domain analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single pull-down for nucleosome binding + yeast interaction + computational topology; moderate evidence\",\n      \"pmids\": [\"24205348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Free-running circadian period lengths are shortened in Rai1+/- mice (gene knock-out) and Df(11)17-2/+ deletion mice but not in Dexras1+/- mice, indicating that Rai1 is the primary gene underlying circadian period defects in Smith-Magenis syndrome models.\",\n      \"method\": \"Free-running period length measurement (locomotor activity in constant dark) in multiple mouse models\",\n      \"journal\": \"American journal of medical genetics. Part A\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis/comparison across multiple mouse models with quantitative circadian phenotype readout\",\n      \"pmids\": [\"23703963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Knockdown of Rai1 in Xenopus laevis/tropicalis using antisense morpholinos causes midface hypoplasia, malformed mouth, aberrant neural crest cell migration, reduced facial cartilage, abnormal axon patterns, decreased forebrain ventricle size, decreased bdnf expression, and increased forebrain apoptosis, revealing a conserved developmental role for Rai1 in neural crest-dependent craniofacial development and neuronal survival.\",\n      \"method\": \"Antisense morpholino knockdown, in situ hybridization, immunostaining, TUNEL apoptosis assay in Xenopus embryos\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function in vertebrate model with multiple cellular/molecular phenotypic readouts\",\n      \"pmids\": [\"24878353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structures of fungal Rai1 homologs bound to RNA oligonucleotides reveal differences in RNA-binding modes that underlie distinct activity profiles (pyrophosphohydrolase vs. triphosphonucleotide hydrolase). Structure-based mutations of poorly conserved residues contacting RNA substantially alter enzymatic activities, establishing the active-site tunnel as the single locus for PPH, decapping, and exonuclease activities.\",\n      \"method\": \"X-ray crystallography, structure-based mutagenesis, RNA enzyme activity assays (PPH, decapping, 5'→3' exonuclease, TPH)\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures with RNA bound + mutagenesis + multiple activity assays; rigorous mechanistic study\",\n      \"pmids\": [\"26101253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Rai1 preferentially occupies DNA regions near active promoters (ChIP-seq in mouse brain) and promotes expression of genes involved in circuit assembly and neuronal communication. Pan-neural Rai1 loss causes deficits in motor function, learning, and food intake; Rai1 loss in inhibitory neurons or subcortical glutamatergic neurons causes learning deficits, while Rai1 loss in Sim1+ or SF1+ hypothalamic cells causes obesity.\",\n      \"method\": \"ChIP-seq (Rai1 chromatin occupancy), conditional Cre/loxP neuron-type-specific knockouts, behavioral testing (motor, learning, feeding)\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genome-wide chromatin binding map + multiple cell-type-specific conditional knockouts with defined phenotypic readouts; strong mechanistic resolution\",\n      \"pmids\": [\"27693255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Normalizing Rai1 levels in Rai1 heterozygous mice at 3–4 weeks postnatal (early adolescence) corrects expression of neural developmental pathway genes and fully reverses a social interaction deficit; Rai1 reactivation at 7–8 weeks is not beneficial, defining a postnatal critical window. Correct Rai1 dosage is required in both excitatory and inhibitory neurons for proper social interaction.\",\n      \"method\": \"Conditional Rai1 reactivation (tet-inducible allele) at defined postnatal timepoints, RNA-seq, social interaction behavioral testing, dendritic spine quantification, optogenetics\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible genetic rescue with temporal precision + transcriptomics + behavioral endpoints; multiple orthogonal methods\",\n      \"pmids\": [\"30275311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DXO/Rai1 enzymes remove FAD and dephospho-CoA (dpCoA) non-canonical caps from RNA (deFADding and deCoAping activities). Crystal structures of mammalian DXO with 3′-FADP or CoA, and fission yeast Rai1 with 3′-FADP, show FAD and CoA adopt folded conformations in the active-site tunnel; the flavin of FAD and pantetheine of CoA contact the same region, with conformational changes accommodating different caps. FAD-capped RNAs (<200 nt) are detected in human cells and stabilized in DXO-null cells.\",\n      \"method\": \"X-ray crystallography (DXO–FADP, DXO–CoA, Rai1–FADP complexes), in vitro deFADding/deCoAping enzyme assays, FAD-capQ detection in human cells, DXO knockout cells\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures with substrates + in vitro enzymatic assays + cellular validation with KO cells\",\n      \"pmids\": [\"32374864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RAI1 binds dynamically to chromatin near active promoters in response to changes in neuronal network activity and is required for activity-dependent nascent transcription. RAI1 suppresses synaptic upscaling in naive networks while promoting upscaling triggered by activity silencing; Rai1-deficient neurons show altered electrophysiological properties consistent with defective homeostatic synaptic plasticity.\",\n      \"method\": \"Nascent RNA sequencing (EU-seq), ChIP-seq (dynamic chromatin occupancy), whole-cell patch clamp electrophysiology in Rai1-deficient neurons\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — nascent transcriptomics + dynamic ChIP-seq + electrophysiology in KO neurons; multiple orthogonal methods\",\n      \"pmids\": [\"32783930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ALKBH5-mediated m6A demethylation of pri-miR-194-2 inhibits miR-194-2 biogenesis in an m6A/DGCR8-dependent manner; RAI1 is the primary target of miR-194-2. RAI1 enhances transcription of Hippo pathway upstream genes by binding to their 3′UTR and suppresses YAP/TAZ nuclear translocation, functioning as a transcriptional enhancer in the Hippo pathway.\",\n      \"method\": \"m6A-seq, DGCR8 RIP, miRNA target validation (luciferase 3′UTR reporter), ChIP/RNA pull-down (RAI1 binding to 3′UTR), YAP/TAZ nuclear translocation assay, in vitro and xenograft models\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple functional assays but mechanistic link (RAI1 binding 3′UTR to enhance Hippo transcription) is somewhat unusual and from a single lab\",\n      \"pmids\": [\"34312488\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RAI1 is a dosage-sensitive nuclear transcriptional activator that occupies active promoters via conserved PHD/ePHD chromatin-reader and nucleosome-binding domains, directly regulates transcription of CLOCK and activity-dependent neuronal genes (including BDNF enhancer targets), controls homeostatic synaptic scaling, and governs circadian rhythmicity and hypothalamic energy balance in a cell-type-specific manner; its yeast/fungal orthologs additionally possess enzymatic activities (pyrophosphohydrolase, decapping, deFADding, deCoAping) directed at non-canonical RNA 5′-end caps, and physically activate the Rat1/XRN2 5′→3′ exoribonuclease through direct complex formation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RAI1 is a dosage-sensitive nuclear transcription factor essential for neurodevelopment, circadian rhythm regulation, and energy homeostasis. It occupies active gene promoters genome-wide, contains chromatin reader modules including an ePHD/ADD-like zinc finger domain and a nucleosome-binding region, and directly transactivates target genes such as CLOCK and BDNF; its haploinsufficiency causes Smith-Magenis syndrome through reduced transcriptional output, while truncating mutations mislocalize the protein to the cytoplasm and C-terminal missense mutations abolish transactivation despite preserved nuclear localization [PMID:12652298, PMID:20738874, PMID:22578325, PMID:27693255]. RAI1 dynamically occupies chromatin in response to neuronal activity changes, regulating nascent transcription of a large fraction of expressed genes and controlling synaptic scaling, and its cell-type-specific loss in distinct neuronal populations produces separable phenotypes including obesity, learning deficits, and social interaction impairments [PMID:32783930, PMID:27693255, PMID:30275311]. Intronic TTTCA repeat expansions in RAI1 cause benign adult familial myoclonic epilepsy type 8 (BAFME8) through a mechanism distinct from haploinsufficiency [PMID:37994247].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing that RAI1 itself—not surrounding genes in the 17p11.2 interval—is the dosage-sensitive locus for Smith-Magenis syndrome resolved the long-standing question of which gene underlies SMS in non-deletion patients.\",\n      \"evidence\": \"Sanger sequencing identified de novo frameshift mutations in RAI1 in non-deletion SMS patients\",\n      \"pmids\": [\"12652298\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which haploinsufficiency produces specific phenotypes unknown\", \"No functional characterization of the protein itself\", \"No animal model yet available\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that Rai1 is a nuclear protein with intrinsic transactivation activity, and that its haploinsufficiency causes obesity and craniofacial defects in mice while homozygous loss is embryonic lethal, established RAI1 as a bona fide transcription factor with dosage-dependent developmental functions.\",\n      \"evidence\": \"GFP-fusion localization, GAL4-fusion transactivation assay, and phenotypic analysis of Rai1+/- and Rai1-/- knockout mice\",\n      \"pmids\": [\"15746153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target genes of RAI1 not identified\", \"Domain structure and chromatin interaction mechanism unknown\", \"No neurobehavioral phenotyping yet performed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetic epistasis showing that normalizing Rai1 copy number rescues Potocki-Lupski syndrome phenotypes in duplication mice proved that both gain and loss of RAI1 dosage—not surrounding genes—drive reciprocal genomic disorder phenotypes.\",\n      \"evidence\": \"Compound heterozygous mice carrying duplication on one chromosome and Rai1 null on the other; behavioral and physical phenotyping\",\n      \"pmids\": [\"17024248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets mediating duplication phenotypes not defined\", \"Whether RAI1 overexpression directly increases transcription of specific genes unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Localizing Rai1 expression predominantly to hippocampal and cerebellar neurons and showing that its loss causes seizures, motor impairment, and learning deficits identified the CNS as the primary organ system underlying SMS neurological features.\",\n      \"evidence\": \"X-gal staining in Rai1+/- mice; behavioral battery including EEG and learning tests\",\n      \"pmids\": [\"17517686\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which neuronal subtypes require Rai1 not resolved\", \"Molecular targets in neurons not identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Dissecting how different SMS mutations impair RAI1 function revealed that truncating and missense mutations operate by distinct mechanisms—cytoplasmic mislocalization versus loss of transactivation with preserved nuclear entry—defining separable functional domains.\",\n      \"evidence\": \"Immunofluorescence, luciferase reporter assays on BDNF enhancer, and western blot analysis of full-length and mutant RAI1 constructs\",\n      \"pmids\": [\"20738874\", \"23028815\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the nuclear localization signal not mapped precisely\", \"C-terminal transactivation domain boundaries not defined\", \"Whether patient-derived mutant protein exerts dominant-negative effects unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying RAI1 as a direct positive transcriptional regulator of CLOCK and showing downstream circadian gene dysregulation in SMS cells and mouse hypothalamus provided the first mechanistic explanation for the inverted melatonin rhythm in SMS patients.\",\n      \"evidence\": \"CLOCK promoter reporter assays; qPCR of circadian genes in SMS fibroblasts and Rai1+/- mouse hypothalamus\",\n      \"pmids\": [\"22578325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RAI1 directly binds the CLOCK promoter in vivo not shown by ChIP at this time\", \"Melatonin pathway regulation not directly tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of conserved chromatin-binding modules—an ePHD/ADD-like zinc finger and a nucleosome-binding region that directly contacts nucleosomes and histones in vitro—placed RAI1 among chromatin reader transcription factors and suggested a mechanism for its promoter occupancy.\",\n      \"evidence\": \"In vitro nucleosome and histone binding assays; phylogenetic and structural analysis\",\n      \"pmids\": [\"24205348\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of RAI1 domains available\", \"Histone mark specificity of the ePHD domain not determined\", \"In vivo relevance of nucleosome binding not demonstrated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Knockdown of Rai1 in Xenopus causing midface hypoplasia, aberrant neural crest migration, and reduced bdnf expression established an evolutionarily conserved requirement for Rai1 in craniofacial and neural development, extending findings beyond mammals.\",\n      \"evidence\": \"Morpholino knockdown in Xenopus; in situ hybridization and developmental phenotyping\",\n      \"pmids\": [\"24878353\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Morpholino off-target effects not fully excluded\", \"Direct transcriptional targets in neural crest not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Genome-wide ChIP-seq revealed that Rai1 preferentially occupies active promoters, and cell-type-specific conditional knockouts decomposed SMS phenotypes into separable circuits—obesity mapping to hypothalamic Sim1+/SF1+ neurons, learning to inhibitory and subcortical glutamatergic neurons—establishing RAI1 as a broad transcriptional regulator with cell-type-specific phenotypic outputs.\",\n      \"evidence\": \"ChIP-seq for Rai1 occupancy; conditional knockouts in multiple neuronal populations; behavioral phenotyping\",\n      \"pmids\": [\"27693255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RAI1 acts as activator or repressor at different loci not resolved genome-wide\", \"Co-factor complexes mediating cell-type-specific activity unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Temporally controlled Rai1 reactivation showed that restoring Rai1 levels during early adolescence (but not later) rescues social deficits and gene expression, defining a critical postnatal window and demonstrating that some SMS phenotypes are reversible rather than hardwired.\",\n      \"evidence\": \"Conditional genetic Rai1 reactivation at defined postnatal ages; RNA-seq; behavioral testing; dendritic spine analysis in medial prefrontal cortex\",\n      \"pmids\": [\"30275311\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism defining the closure of the critical window unknown\", \"Whether other SMS phenotypes (obesity, circadian) are similarly reversible not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating that RAI1 dynamically remodels its chromatin occupancy in response to neuronal activity and regulates nascent transcription of ~45% of expressed genes during synaptic scaling established RAI1 as a central activity-dependent transcriptional regulator rather than a static developmental factor.\",\n      \"evidence\": \"Nascent RNA-seq (EU-seq), dynamic ChIP-seq, and mEPSC recording in Rai1-deficient neurons\",\n      \"pmids\": [\"32783930\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal transduction pathway linking activity to RAI1 chromatin remodeling unknown\", \"Whether RAI1 is phosphorylated or otherwise post-translationally modified in response to activity not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery that intronic TTTCA repeat expansions in RAI1 cause BAFME8 without reducing RAI1 mRNA levels revealed a second disease mechanism at the RAI1 locus, distinct from haploinsufficiency, implicating repeat-mediated toxicity.\",\n      \"evidence\": \"Long-read whole-genome sequencing; repeat-primed PCR; RNA quantification in patient leukocytes\",\n      \"pmids\": [\"37994247\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Repeat RNA toxicity versus other repeat expansion mechanisms not discriminated\", \"No functional studies on neuronal consequences of the repeat expansion\", \"Whether repeat expansion affects RAI1 protein function or splicing not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of RAI1's co-factor complexes and direct protein partners at promoters, the post-translational modifications regulating its activity-dependent chromatin dynamics, and the structural basis for histone mark recognition by its ePHD/ADD domain.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No co-factor complex purified or identified\", \"No high-resolution structure of any RAI1 domain\", \"Post-translational regulation entirely uncharacterized\", \"Mechanism of repeat-expansion-mediated BAFME8 pathogenesis unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 5, 6, 7, 11, 13]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [11, 13]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 5, 7]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [7, 9, 11, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 5, 6, 11, 13]},\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [6, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [10, 12]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [4, 11, 12, 13]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [9, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CLOCK\",\n      \"BDNF\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"RAI1 is a dosage-sensitive nuclear transcriptional activator essential for neurodevelopment, circadian rhythmicity, and energy homeostasis. It localizes to chromatin via a C-terminal ePHD/ADD-like domain and a conserved nucleosome-binding region, occupies active promoters in a neuronal activity-dependent manner, and directly transactivates targets including CLOCK and BDNF enhancer elements [PMID:22578325, PMID:32783930, PMID:24205348]. Haploinsufficiency of RAI1 causes Smith–Magenis syndrome, while its overexpression produces Potocki–Lupski syndrome features, reflecting strict copy-number thresholds for normal CNS function [PMID:12652298, PMID:17024248]. Cell-type-specific conditional knockouts demonstrate that RAI1 in hypothalamic neurons governs body weight, while its activity in cortical excitatory and inhibitory neurons controls homeostatic synaptic scaling, social behavior, and learning within a postnatal critical window [PMID:27693255, PMID:30275311, PMID:32783930].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of a physical and functional partnership between yeast Rai1p and the nuclear exoribonuclease Rat1p established the founding biochemical activity of the Rai1 family — stabilizing and stimulating 5′→3′ exoribonuclease activity and participating in rRNA processing.\",\n      \"evidence\": \"Yeast two-hybrid, co-purification, in vitro exoribonuclease stimulation assay, synthetic lethality with rat1-1(ts), Northern blot rRNA analysis in S. cerevisiae\",\n      \"pmids\": [\"10805743\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian RAI1 retains exoribonuclease-stimulating or pyrophosphohydrolase activity was unknown\", \"Relevance of the Rat1 partnership to metazoan RAI1 function not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Cloning of human RAI1 and discovery that truncating mutations in RAI1 alone are sufficient to produce Smith–Magenis syndrome established RAI1 haploinsufficiency as the molecular basis for SMS, separating it from the broader 17p11.2 contiguous gene deletion.\",\n      \"evidence\": \"cDNA cloning, mutation screening of non-deletion SMS patients identifying frameshift mutations, RT-PCR expression profiling\",\n      \"pmids\": [\"12652298\", \"12837267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular function of RAI1 protein in mammalian cells was entirely uncharacterized\", \"No structural or biochemical data for mammalian RAI1\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstration that RAI1 is a nuclear protein with intrinsic transcriptional activation activity, and that heterozygous Rai1-null mice recapitulate SMS phenotypes, provided the first functional classification of RAI1 as a dosage-sensitive transcriptional activator.\",\n      \"evidence\": \"Gene-targeted Rai1-null mice, GFP-Rai1 nuclear localization, GAL4-Rai1 transactivation reporter assay\",\n      \"pmids\": [\"15746153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target genes of RAI1 transactivation unknown\", \"Chromatin-binding mechanism unresolved\", \"Pathway specificity of dosage sensitivity not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetic rescue of the dup(17)(p11.2) mouse phenotype by normalizing Rai1 copy number proved that RAI1 is the critical dosage-sensitive gene underlying both deletion (SMS) and duplication (Potocki–Lupski) syndromes.\",\n      \"evidence\": \"Compound heterozygous Dp(11)17/Rai1-null mouse genetics with behavioral and physical phenotyping\",\n      \"pmids\": [\"17024248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular and circuit-level mechanisms of dosage sensitivity not identified\", \"Whether dosage effects are transcriptional or post-transcriptional unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Crystal structures of the S. pombe Rat1–Rai1 complex and free Rai1/Dom3Z revealed the structural basis by which Rai1 activates Rat1 exoribonuclease activity, and uncovered an intrinsic pyrophosphohydrolase activity in the Rai1 active-site pocket — the first such eukaryotic activity — broadening the enzymatic repertoire of the family.\",\n      \"evidence\": \"X-ray crystallography (2.0–2.2 Å), in vitro exoribonuclease and pyrophosphohydrolase assays, active-site mutagenesis\",\n      \"pmids\": [\"19194460\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian RAI1 retains enzymatic activity or only transcriptional function was unclear\", \"Structural basis for mammalian RAI1 chromatin interaction not addressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Domain-dissection of human RAI1 established that N-terminal truncation mutations displace the protein from the nucleus and abolish BDNF enhancer transactivation, while C-terminal missense mutations retain nuclear localization but still lose transactivation, defining separable localization and activation domains.\",\n      \"evidence\": \"Immunofluorescence, luciferase reporter assays with wild-type and mutant RAI1 constructs, patient lymphoblastoid cell fractionation\",\n      \"pmids\": [\"20738874\", \"23028815\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of direct chromatin-binding domain not resolved\", \"Genome-wide target repertoire unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that RAI1 directly activates the CLOCK promoter and that RAI1 haploinsufficiency disrupts downstream circadian gene oscillation established RAI1 as a transcriptional regulator of the mammalian circadian clock.\",\n      \"evidence\": \"CLOCK promoter-luciferase reporter, RT-qPCR of circadian genes in SMS patient fibroblasts and Rai1+/− mouse hypothalamus\",\n      \"pmids\": [\"22578325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RAI1 binds CLOCK promoter chromatin directly (ChIP) not shown\", \"Mechanism linking RAI1 to circadian period length not fully resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of a conserved ePHD/ADD-like domain and a nucleosome-binding region in RAI1, combined with demonstration of direct nucleosome core binding, provided the first chromatin-reader mechanism for how RAI1 engages its genomic targets; concurrently, free-running circadian period shortening in Rai1+/− mice confirmed RAI1 as the gene responsible for SMS-associated circadian defects.\",\n      \"evidence\": \"In vitro nucleosome pull-down, yeast two-hybrid for ePHD topology, free-running locomotor activity in constant darkness across multiple mouse models\",\n      \"pmids\": [\"24205348\", \"23703963\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ePHD/nucleosome-binding interaction lacks structural resolution at atomic level\", \"Histone mark specificity of ePHD reader not determined\", \"In vivo ChIP validation of nucleosome-binding region absent\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystal structures of fungal Rai1 homologs bound to RNA substrates revealed how active-site tunnel geometry dictates substrate specificity among pyrophosphohydrolase, decapping, and triphosphonucleotide hydrolase activities, unifying diverse cap-removal functions in a single catalytic locus.\",\n      \"evidence\": \"X-ray crystallography with RNA oligonucleotides, structure-based mutagenesis, PPH/decapping/exonuclease activity assays\",\n      \"pmids\": [\"26101253\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic activities demonstrated for fungal orthologs; metazoan RAI1 enzymatic activity not confirmed\", \"In vivo RNA substrates of Rai1 cap-removal not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Genome-wide ChIP-seq demonstrated that Rai1 preferentially occupies active promoters in mouse brain, and cell-type-specific conditional knockouts revealed circuit-level division of labor: hypothalamic Rai1 controls energy balance while cortical/subcortical Rai1 governs learning and motor function.\",\n      \"evidence\": \"ChIP-seq in mouse brain, Cre/loxP conditional knockouts in inhibitory, excitatory, Sim1+, and SF1+ neurons with behavioral phenotyping\",\n      \"pmids\": [\"27693255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors mediating RAI1 recruitment to active promoters unidentified\", \"Mechanism by which RAI1 activates transcription at bound promoters unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Temporal genetic rescue experiments defined a postnatal critical window (~3–4 weeks) during which restoring Rai1 dosage normalizes neural gene expression and social behavior, demonstrating that RAI1 function is required during a developmental period and not merely for ongoing maintenance.\",\n      \"evidence\": \"Tet-inducible Rai1 reactivation at defined postnatal ages, RNA-seq, social interaction testing, dendritic spine analysis\",\n      \"pmids\": [\"30275311\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of the critical window closure unknown\", \"Whether the window applies to all SMS phenotypes or only social behavior untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Two advances converged: (1) structural and biochemical demonstration that DXO/Rai1 enzymes remove non-canonical FAD and CoA caps from RNA, expanding the cap-removal repertoire; and (2) dynamic ChIP-seq and nascent transcriptomics showing RAI1 chromatin occupancy responds to neuronal activity changes and is required for homeostatic synaptic scaling, connecting RAI1 to activity-dependent gene regulation and synaptic plasticity.\",\n      \"evidence\": \"X-ray crystallography (DXO–FADP, Rai1–FADP), in vitro deFADding/deCoAping assays, DXO-KO cells; EU-seq, dynamic ChIP-seq, whole-cell patch clamp in Rai1-deficient neurons\",\n      \"pmids\": [\"32374864\", \"32783930\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian RAI1 (as opposed to DXO) retains deFADding/deCoAping activity in neurons is untested\", \"Specific activity-dependent target genes directly controlled by RAI1 chromatin binding not fully catalogued\", \"Structural basis for mammalian RAI1 chromatin engagement still lacking\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: whether mammalian RAI1 retains any enzymatic (cap-removal) activity or functions exclusively as a transcription factor; the structural basis of RAI1's ePHD-mediated chromatin reading and histone-mark specificity; the identity of RAI1's cofactors and the transcriptional complex it operates within; and the molecular mechanism defining the postnatal critical window for RAI1-dependent circuit maturation.\",\n      \"evidence\": \"Open questions arising from the literature\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of mammalian RAI1 available\", \"No identified cofactors or chromatin-remodeling complex partners\", \"Enzymatic versus transcriptional roles in mammalian neurons not delineated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [4, 9, 10, 11, 16, 19]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [16, 19]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [8, 15, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 4, 9, 11]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [11, 12, 16, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009909396\", \"supporting_discovery_ids\": [10, 13]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 9, 10, 16, 19]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [12, 16, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [14, 17]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [6, 16, 17, 19]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 8, 15, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CLOCK\",\n      \"BDNF\",\n      \"RAT1\",\n      \"XRN2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to fix the circadian clock pathway term_id. Let me correct it — the circadian clock Reactome ID is `R-HSA-9909396`, not `GO:0009909396`.\n\n```json\n{\n  \"mechanistic_narrative\": \"RAI1 is a dosage-sensitive nuclear transcriptional activator essential for neurodevelopment, circadian rhythmicity, and energy homeostasis. It localizes to chromatin via a C-terminal ePHD/ADD-like domain and a conserved nucleosome-binding region, occupies active promoters in a neuronal activity-dependent manner, and directly transactivates targets including CLOCK and BDNF enhancer elements [PMID:22578325, PMID:32783930, PMID:24205348]. Haploinsufficiency of RAI1 causes Smith–Magenis syndrome, while its overexpression produces Potocki–Lupski syndrome features, reflecting strict copy-number thresholds for normal CNS function [PMID:12652298, PMID:17024248]. Cell-type-specific conditional knockouts demonstrate that RAI1 in hypothalamic neurons governs body weight, while its activity in cortical excitatory and inhibitory neurons controls homeostatic synaptic scaling, social behavior, and learning within a postnatal critical window [PMID:27693255, PMID:30275311, PMID:32783930].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of a physical and functional partnership between yeast Rai1p and the nuclear exoribonuclease Rat1p established the founding biochemical activity of the Rai1 family — stabilizing and stimulating 5′→3′ exoribonuclease activity and participating in rRNA processing.\",\n      \"evidence\": \"Yeast two-hybrid, co-purification, in vitro exoribonuclease stimulation assay, synthetic lethality with rat1-1(ts), Northern blot rRNA analysis in S. cerevisiae\",\n      \"pmids\": [\"10805743\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian RAI1 retains exoribonuclease-stimulating or pyrophosphohydrolase activity was unknown\", \"Relevance of the Rat1 partnership to metazoan RAI1 function not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Cloning of human RAI1 and discovery that truncating mutations in RAI1 alone are sufficient to produce Smith–Magenis syndrome established RAI1 haploinsufficiency as the molecular basis for SMS, separating it from the broader 17p11.2 contiguous gene deletion.\",\n      \"evidence\": \"cDNA cloning, mutation screening of non-deletion SMS patients identifying frameshift mutations, RT-PCR expression profiling\",\n      \"pmids\": [\"12652298\", \"12837267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular function of RAI1 protein in mammalian cells was entirely uncharacterized\", \"No structural or biochemical data for mammalian RAI1\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstration that RAI1 is a nuclear protein with intrinsic transcriptional activation activity, and that heterozygous Rai1-null mice recapitulate SMS phenotypes, provided the first functional classification of RAI1 as a dosage-sensitive transcriptional activator.\",\n      \"evidence\": \"Gene-targeted Rai1-null mice, GFP-Rai1 nuclear localization, GAL4-Rai1 transactivation reporter assay\",\n      \"pmids\": [\"15746153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target genes of RAI1 transactivation unknown\", \"Chromatin-binding mechanism unresolved\", \"Pathway specificity of dosage sensitivity not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetic rescue of the dup(17)(p11.2) mouse phenotype by normalizing Rai1 copy number proved that RAI1 is the critical dosage-sensitive gene underlying both deletion (SMS) and duplication (Potocki–Lupski) syndromes.\",\n      \"evidence\": \"Compound heterozygous Dp(11)17/Rai1-null mouse genetics with behavioral and physical phenotyping\",\n      \"pmids\": [\"17024248\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular and circuit-level mechanisms of dosage sensitivity not identified\", \"Whether dosage effects are transcriptional or post-transcriptional unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Crystal structures of the S. pombe Rat1–Rai1 complex and free Rai1/Dom3Z revealed the structural basis by which Rai1 activates Rat1 exoribonuclease activity, and uncovered an intrinsic pyrophosphohydrolase activity in the Rai1 active-site pocket — the first such eukaryotic activity — broadening the enzymatic repertoire of the family.\",\n      \"evidence\": \"X-ray crystallography (2.0–2.2 Å), in vitro exoribonuclease and pyrophosphohydrolase assays, active-site mutagenesis\",\n      \"pmids\": [\"19194460\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian RAI1 retains enzymatic activity or only transcriptional function was unclear\", \"Structural basis for mammalian RAI1 chromatin interaction not addressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Domain-dissection of human RAI1 established that N-terminal truncation mutations displace the protein from the nucleus and abolish BDNF enhancer transactivation, while C-terminal missense mutations retain nuclear localization but still lose transactivation, defining separable localization and activation domains.\",\n      \"evidence\": \"Immunofluorescence, luciferase reporter assays with wild-type and mutant RAI1 constructs, patient lymphoblastoid cell fractionation\",\n      \"pmids\": [\"20738874\", \"23028815\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of direct chromatin-binding domain not resolved\", \"Genome-wide target repertoire unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that RAI1 directly activates the CLOCK promoter and that RAI1 haploinsufficiency disrupts downstream circadian gene oscillation established RAI1 as a transcriptional regulator of the mammalian circadian clock.\",\n      \"evidence\": \"CLOCK promoter-luciferase reporter, RT-qPCR of circadian genes in SMS patient fibroblasts and Rai1+/− mouse hypothalamus\",\n      \"pmids\": [\"22578325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RAI1 binds CLOCK promoter chromatin directly (ChIP) not shown\", \"Mechanism linking RAI1 to circadian period length not fully resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identification of a conserved ePHD/ADD-like domain and a nucleosome-binding region in RAI1, combined with demonstration of direct nucleosome core binding, provided the first chromatin-reader mechanism for how RAI1 engages its genomic targets; concurrently, free-running circadian period shortening in Rai1+/− mice confirmed RAI1 as the gene responsible for SMS-associated circadian defects.\",\n      \"evidence\": \"In vitro nucleosome pull-down, yeast two-hybrid for ePHD topology, free-running locomotor activity in constant darkness across multiple mouse models\",\n      \"pmids\": [\"24205348\", \"23703963\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ePHD/nucleosome-binding interaction lacks structural resolution at atomic level\", \"Histone mark specificity of ePHD reader not determined\", \"In vivo ChIP validation of nucleosome-binding region absent\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystal structures of fungal Rai1 homologs bound to RNA substrates revealed how active-site tunnel geometry dictates substrate specificity among pyrophosphohydrolase, decapping, and triphosphonucleotide hydrolase activities, unifying diverse cap-removal functions in a single catalytic locus.\",\n      \"evidence\": \"X-ray crystallography with RNA oligonucleotides, structure-based mutagenesis, PPH/decapping/exonuclease activity assays\",\n      \"pmids\": [\"26101253\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Catalytic activities demonstrated for fungal orthologs; metazoan RAI1 enzymatic activity not confirmed\", \"In vivo RNA substrates of Rai1 cap-removal not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Genome-wide ChIP-seq demonstrated that Rai1 preferentially occupies active promoters in mouse brain, and cell-type-specific conditional knockouts revealed circuit-level division of labor: hypothalamic Rai1 controls energy balance while cortical/subcortical Rai1 governs learning and motor function.\",\n      \"evidence\": \"ChIP-seq in mouse brain, Cre/loxP conditional knockouts in inhibitory, excitatory, Sim1+, and SF1+ neurons with behavioral phenotyping\",\n      \"pmids\": [\"27693255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors mediating RAI1 recruitment to active promoters unidentified\", \"Mechanism by which RAI1 activates transcription at bound promoters unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Temporal genetic rescue experiments defined a postnatal critical window (~3–4 weeks) during which restoring Rai1 dosage normalizes neural gene expression and social behavior, demonstrating that RAI1 function is required during a developmental period and not merely for ongoing maintenance.\",\n      \"evidence\": \"Tet-inducible Rai1 reactivation at defined postnatal ages, RNA-seq, social interaction testing, dendritic spine analysis\",\n      \"pmids\": [\"30275311\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of the critical window closure unknown\", \"Whether the window applies to all SMS phenotypes or only social behavior untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Two advances converged: (1) structural and biochemical demonstration that DXO/Rai1 enzymes remove non-canonical FAD and CoA caps from RNA, expanding the cap-removal repertoire; and (2) dynamic ChIP-seq and nascent transcriptomics showing RAI1 chromatin occupancy responds to neuronal activity changes and is required for homeostatic synaptic scaling, connecting RAI1 to activity-dependent gene regulation and synaptic plasticity.\",\n      \"evidence\": \"X-ray crystallography (DXO–FADP, Rai1–FADP), in vitro deFADding/deCoAping assays, DXO-KO cells; EU-seq, dynamic ChIP-seq, whole-cell patch clamp in Rai1-deficient neurons\",\n      \"pmids\": [\"32374864\", \"32783930\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian RAI1 (as opposed to DXO) retains deFADding/deCoAping activity in neurons is untested\", \"Specific activity-dependent target genes directly controlled by RAI1 chromatin binding not fully catalogued\", \"Structural basis for mammalian RAI1 chromatin engagement still lacking\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: whether mammalian RAI1 retains any enzymatic (cap-removal) activity or functions exclusively as a transcription factor; the structural basis of RAI1's ePHD-mediated chromatin reading and histone-mark specificity; the identity of RAI1's cofactors and the transcriptional complex it operates within; and the molecular mechanism defining the postnatal critical window for RAI1-dependent circuit maturation.\",\n      \"evidence\": \"Open questions arising from the literature\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of mammalian RAI1 available\", \"No identified cofactors or chromatin-remodeling complex partners\", \"Enzymatic versus transcriptional roles in mammalian neurons not delineated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [4, 9, 10, 11, 16, 19]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [16, 19]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [8, 15, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 4, 9, 11]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [11, 16, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9909396\", \"supporting_discovery_ids\": [10, 13]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 9, 10, 16, 19]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [12, 16, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [14, 17]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [6, 16, 17, 19]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 8, 15, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CLOCK\",\n      \"BDNF\",\n      \"RAT1\",\n      \"XRN2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}